The	DT	B-NP	O	Other	No	No	Other	Other	###	1	The	The	DT	DT	_	2	det	_	_
exposure	NN	I-NP	O	Other	No	No	Other	Other	###	2	exposure	exposure	NN	NN	_	12	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	3	of	of	IN	IN	_	5	case	_	_
inflammatory	JJ	B-NP	B-cell_type	Other	No	No	Other	Other	###	4	inflammatory	inflammatory	JJ	JJ	_	5	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	No	No	Other	Other	###	5	cells	cells	NNS	NNS	_	2	nmod	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	6	to	to	TO	TO	_	8	case	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	7	a	a	DT	DT	_	8	det	_	_
variety	NN	I-NP	O	Other	No	No	Other	Other	###	8	variety	variety	NN	NN	_	2	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	9	of	of	IN	IN	_	11	case	_	_
extracellular	JJ	B-NP	O	Other	No	No	Other	Other	###	10	extracellular	extracellular	JJ	JJ	_	11	amod	_	_
stimuli	NNS	I-NP	O	Other	No	No	Other	Other	###	11	stimuli	stimuli	NNS	NNS	_	8	nmod	_	_
results	VBZ	B-VP	O	Other	No	No	Other	Other	###	12	results	results	VBZ	VBZ	_	0	root	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	13	in	in	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	14	the	the	DT	DT	_	15	det	_	_
initiation	NN	I-NP	O	Other	No	No	Other	Other	###	15	initiation	initiation	NN	NN	_	12	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	16	of	of	IN	IN	_	20	case	_	_
transcriptional	JJ	B-NP	O	Other	No	No	Other	Other	###	17	transcriptional	transcriptional	JJ	JJ	_	20	amod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	18	and	and	CC	CC	_	17	cc	_	_
posttranscriptional	JJ	I-NP	O	Other	No	No	Other	Other	###	19	posttranscriptional	posttranscriptional	JJ	JJ	_	17	conj	_	_
events	NNS	I-NP	O	Other	No	No	Other	Other	###	20	events	events	NNS	NNS	_	15	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	21	,	,	,	,	_	20	punct	_	_
which	WDT	B-NP	O	Other	No	No	Other	Other	###	22	which	which	WDT	WDT	_	23	nsubj	_	_
culminate	VBP	B-VP	O	Other	No	No	Other	Other	###	23	culminate	culminate	VBP	VBP	_	20	acl:relcl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	24	in	in	IN	IN	_	26	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	25	the	the	DT	DT	_	26	det	_	_
production	NN	I-NP	O	Other	No	No	Other	Other	###	26	production	production	NN	NN	_	23	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	27	of	of	IN	IN	_	30	case	_	_
pro-inflammatory	JJ	B-NP	B-protein	Other	No	No	Other	Other	###	28	pro-inflammatory	pro-inflammatory	JJ	JJ	_	30	amod	_	_
mediators.11-14	NN	I-NP	I-protein	Other	No	No	Other	Other	###	29	mediators.11-14	mediators.11-14	NN	NN	_	30	compound	_	_
TNF-alpha	NN	I-NP	I-protein	B-Protein	No	No	B-Protein	Other	###	30	TNF-alpha	TNF-alpha	NN	NN	_	26	nmod	_	_
is	VBZ	B-VP	O	Other	No	No	Other	Other	###	31	is	is	VBZ	VBZ	_	32	auxpass	_	_
released	VBN	I-VP	O	Other	No	No	Other	B-Localization	###	32	released	released	VBN	VBN	_	15	acl:relcl	_	_
very	RB	B-NP	O	Other	No	No	Other	Other	###	33	very	very	RB	RB	_	34	advmod	_	_
early	JJ	I-NP	O	Other	No	No	Other	Other	###	34	early	early	JJ	JJ	_	36	advmod	_	_
following	VBG	I-NP	O	Other	No	No	Other	B-Positive_regulation	###	35	following	following	VBG	VBG	_	36	case	_	_
shock	NN	I-NP	O	Other	No	No	Other	Other	###	36	shock	shock	NN	NN	_	32	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	37	and	and	CC	CC	_	32	cc	_	_
is	VBZ	B-VP	O	Other	No	No	Other	Other	###	38	is	is	VBZ	VBZ	_	39	auxpass	_	_
considered	VBN	I-VP	O	Other	No	No	Other	Other	###	39	considered	considered	VBN	VBN	_	32	conj	_	_
an	DT	B-NP	O	Other	No	No	Other	Other	###	40	an	an	DT	DT	_	42	det	_	_
important	JJ	I-NP	O	Other	No	No	Other	Other	###	41	important	important	JJ	JJ	_	42	amod	_	_
mediator	NN	I-NP	O	Other	No	No	Other	Other	###	42	mediator	mediator	NN	NN	_	39	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	43	of	of	IN	IN	_	46	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	44	the	the	DT	DT	_	46	det	_	_
inflammatory	JJ	I-NP	O	Other	No	No	Other	Other	###	45	inflammatory	inflammatory	JJ	JJ	_	46	amod	_	_
cascade	NN	I-NP	O	Other	No	No	Other	Other	###	46	cascade	cascade	NN	NN	_	42	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	47	,	,	,	,	_	32	punct	_	_
since	IN	B-SBAR	O	Other	No	No	Other	Other	###	48	since	since	IN	IN	_	50	mark	_	_
it	PRP	B-NP	O	Other	No	No	Other	Other	###	49	it	it	PRP	PRP	_	50	nsubj	_	_
regulates	VBZ	B-VP	O	Other	No	No	Other	Other	###	50	regulates	regulates	VBZ	VBZ	_	32	advcl	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	51	the	the	DT	DT	_	52	det	_	_
synthesis	NN	I-NP	O	Other	No	No	Other	Other	###	52	synthesis	synthesis	NN	NN	_	50	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	53	of	of	IN	IN	_	57	case	_	_
several	JJ	B-NP	O	Other	No	No	Other	Other	###	54	several	several	JJ	JJ	_	55	amod	_	_
other	JJ	I-NP	O	Other	No	No	Other	Other	###	55	other	other	JJ	JJ	_	57	amod	_	_
critical	JJ	I-NP	O	Other	No	No	Other	Other	###	56	critical	critical	JJ	JJ	_	57	amod	_	_
cytokines	NNS	I-NP	B-protein	Other	No	No	Other	Other	###	57	cytokines	cytokines	NNS	NNS	_	52	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	58	and	and	CC	CC	_	57	cc	_	_
chemokines.15	NN	B-NP	B-protein	Other	No	No	Other	Other	###	59	chemokines.15	chemokines.15	NN	NN	_	62	compound	_	_
A	NN	I-NP	I-protein	Other	No	No	Other	Other	###	60	A	A	NN	NN	_	62	compound	_	_
clear	JJ	I-NP	O	Other	No	No	Other	Other	###	61	clear	clear	JJ	JJ	_	62	amod	_	_
relationship	NN	I-NP	O	Other	No	No	Other	Other	###	62	relationship	relationship	NN	NN	_	78	nsubjpass	_	_
between	IN	B-PP	O	Other	No	No	Other	Other	###	63	between	between	IN	IN	_	66	case	_	_
increased	VBN	B-NP	O	Other	No	No	Other	B-Positive_regulation	###	64	increased	increased	VBN	VBN	_	66	amod	_	_
TNF-alpha	NN	I-NP	B-protein	B-Protein	No	No	B-Protein	Other	###	65	TNF-alpha	TNF-alpha	NN	NN	_	66	compound	_	_
synthesis	NN	I-NP	O	Other	No	No	Other	B-Gene_expression	###	66	synthesis	synthesis	NN	NN	_	62	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	67	and	and	CC	CC	_	66	cc	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	68	the	the	DT	DT	_	69	det	_	_
development	NN	I-NP	O	Other	No	No	Other	Other	###	69	development	development	NN	NN	_	66	conj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	70	of	of	IN	IN	_	71	case	_	_
shock	NN	B-NP	O	Other	No	No	Other	Other	###	71	shock	shock	NN	NN	_	69	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	72	and	and	CC	CC	_	71	cc	_	_
multiple	JJ	B-NP	O	Other	No	No	Other	Other	###	73	multiple	multiple	JJ	JJ	_	75	amod	_	_
organ	NN	I-NP	O	Other	No	No	Other	Other	###	74	organ	organ	NN	NN	_	75	compound	_	_
dysfunction	NN	I-NP	O	Other	No	No	Other	Other	###	75	dysfunction	dysfunction	NN	NN	_	71	conj	_	_
has	VBZ	B-VP	O	Other	No	No	Other	Other	###	76	has	has	VBZ	VBZ	_	78	aux	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	77	been	been	VBN	VBN	_	78	auxpass	_	_
observed	VBN	I-VP	O	Other	No	No	Other	Other	###	78	observed	observed	VBN	VBN	_	50	conj	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	79	in	in	IN	IN	_	81	case	_	_
animal	NN	B-NP	O	Other	No	No	Other	Other	###	80	animal	animal	NN	NN	_	81	compound	_	_
models	NNS	I-NP	O	Other	No	No	Other	Other	###	81	models	models	NNS	NNS	_	78	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	82	of	of	IN	IN	_	83	case	_	_
sepsis.15-17	NN	B-NP	O	Other	No	No	Other	Other	###	83	sepsis.15-17	sepsis.15-17	NN	NN	_	81	nmod	_	_

Because	IN	B-PP	O	Other	No	No	Other	Other	###	1	Because	Because	IN	IN	_	4	case	_	_
of	IN	I-PP	O	Other	No	No	Other	Other	###	2	of	of	IN	IN	_	4	case	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	3	its	its	PRP$	PRP$	_	4	nmod:poss	_	_
importance	NN	I-NP	O	Other	No	No	Other	Other	###	4	importance	importance	NN	NN	_	24	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	5	in	in	IN	IN	_	6	mark	_	_
orchestrating	VBG	B-VP	O	Other	No	No	Other	Other	###	6	orchestrating	orchestrating	VBG	VBG	_	4	acl	_	_
multiple	JJ	B-NP	O	Other	No	No	Other	Other	###	7	multiple	multiple	JJ	JJ	_	8	amod	_	_
steps	NNS	I-NP	O	Other	No	No	Other	Other	###	8	steps	steps	NNS	NNS	_	6	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	9	of	of	IN	IN	_	12	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	10	the	the	DT	DT	_	12	det	_	_
inflammatory	JJ	I-NP	O	Other	No	No	Other	Other	###	11	inflammatory	inflammatory	JJ	JJ	_	12	amod	_	_
response	NN	I-NP	O	Other	No	No	Other	Other	###	12	response	response	NN	NN	_	8	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	13	,	,	,	,	_	24	punct	_	_
strategies	NNS	B-NP	O	Other	No	No	Other	Other	###	14	strategies	strategies	NNS	NNS	_	24	nsubj	_	_
aimed	VBN	B-VP	O	Other	No	No	Other	Other	###	15	aimed	aimed	VBN	VBN	_	14	acl	_	_
at	IN	B-PP	O	Other	No	No	Other	Other	###	16	at	at	IN	IN	_	17	mark	_	_
decreasing	VBG	B-VP	O	Other	No	No	Other	B-Negative_regulation	###	17	decreasing	decreasing	VBG	VBG	_	15	advcl	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	18	TNF-alpha	TNF-alpha	NN	NN	_	19	compound	_	_
levels	NNS	I-NP	O	Other	No	No	Other	Other	###	19	levels	levels	NNS	NNS	_	17	dobj	_	_
or	CC	O	O	Other	No	No	Other	Other	###	20	or	or	CC	CC	_	17	cc	_	_
attenuating	VBG	B-VP	O	Other	No	No	Other	B-Negative_regulation	###	21	attenuating	attenuating	VBG	VBG	_	17	conj	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	22	its	its	PRP$	PRP$	_	23	nmod:poss	_	_
production	NN	I-NP	O	Other	No	No	Other	B-Gene_expression	###	23	production	production	NN	NN	_	21	dobj	_	_
seem	VBP	B-VP	O	Other	No	No	Other	Other	###	24	seem	seem	VBP	VBP	_	0	root	_	_
attractive	JJ	B-ADJP	O	Other	No	No	Other	Other	###	25	attractive	attractive	JJ	JJ	_	24	xcomp	_	_
.	.	O	O	Other	No	No	Other	Other	###	26	.	.	.	.	_	24	punct	_	_

PDE	NN	B-NP	O	Other	No	No	Other	Other	###	1	PDE	PDE	NN	NN	_	2	compound	_	_
inhibitors	NNS	I-NP	O	Other	No	No	Other	Other	###	2	inhibitors	inhibitors	NNS	NNS	_	5	nsubjpass	_	_
have	VBP	B-VP	O	Other	No	No	Other	Other	###	3	have	have	VBP	VBP	_	5	aux	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	4	been	been	VBN	VBN	_	5	auxpass	_	_
shown	VBN	I-VP	O	Other	No	No	Other	Other	###	5	shown	shown	VBN	VBN	_	0	root	_	_
to	TO	I-VP	O	Other	No	No	Other	Other	###	6	to	to	TO	TO	_	7	mark	_	_
downregulate	VB	I-VP	O	Other	No	No	Other	B-Negative_regulation	###	7	downregulate	downregulate	VB	VB	_	5	xcomp	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	8	TNF-alpha	TNF-alpha	NN	NN	_	9	compound	_	_
production	NN	I-NP	O	Other	No	Yes	Other	B-Gene_expression	###	9	production	production	NN	NN	_	7	dobj	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	10	in	in	IN	IN	_	14	case	_	_
distinct	JJ	B-NP	O	Other	No	No	Other	Other	###	11	distinct	distinct	JJ	JJ	_	14	amod	_	_
human	JJ	I-NP	O	Other	No	No	Other	Other	###	12	human	human	JJ	JJ	_	14	amod	_	_
cell	NN	I-NP	O	Other	No	No	Other	Other	###	13	cell	cell	NN	NN	_	14	compound	_	_
populations	NNS	I-NP	O	Other	No	No	Other	Other	###	14	populations	populations	NNS	NNS	_	7	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	15	.	.	.	.	_	5	punct	_	_

We	PRP	B-NP	O	Other	No	No	Other	Other	###	1	We	We	PRP	PRP	_	4	nsubj	_	_
have	VBP	B-VP	O	Other	No	No	Other	Other	###	2	have	have	VBP	VBP	_	4	aux	_	_
previously	RB	I-VP	O	Other	No	No	Other	Other	###	3	previously	previously	RB	RB	_	4	advmod	_	_
shown	VBN	I-VP	O	Other	No	No	Other	Other	###	4	shown	shown	VBN	VBN	_	0	root	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	5	that	that	IN	IN	_	12	mark	_	_
,	,	O	O	Other	No	No	Other	Other	###	6	,	,	,	,	_	12	punct	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	7	in	in	IN	IN	_	8	case	_	_
general	JJ	B-ADJP	O	Other	No	No	Other	Other	###	8	general	general	JJ	JJ	_	12	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	9	,	,	,	,	_	12	punct	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	10	TNF-alpha	TNF-alpha	NN	NN	_	11	compound	_	_
levels	NNS	I-NP	O	Other	No	No	Other	Other	###	11	levels	levels	NNS	NNS	_	12	nsubj	_	_
continue	VBP	B-VP	O	Other	No	No	Other	Other	###	12	continue	continue	VBP	VBP	_	4	ccomp	_	_
to	TO	I-VP	O	Other	No	No	Other	Other	###	13	to	to	TO	TO	_	14	mark	_	_
increase	VB	I-VP	O	Other	No	No	Other	B-Positive_regulation	###	14	increase	increase	VB	VB	_	12	xcomp	_	_
after	IN	B-PP	O	Other	No	No	Other	Other	###	15	after	after	IN	IN	_	17	case	_	_
LPS	NN	B-NP	O	Other	No	No	Other	Other	###	16	LPS	LPS	NN	NN	_	17	compound	_	_
exposure	NN	I-NP	O	Other	No	No	Other	Other	###	17	exposure	exposure	NN	NN	_	14	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	18	and	and	CC	CC	_	12	cc	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	19	that	that	IN	IN	_	27	mark	_	_
concomitant	JJ	B-NP	O	Other	No	No	Other	Other	###	20	concomitant	concomitant	JJ	JJ	_	21	amod	_	_
infusion	NN	I-NP	O	Other	No	No	Other	Other	###	21	infusion	infusion	NN	NN	_	27	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	22	of	of	IN	IN	_	24	case	_	_
phosphodiesterase	NN	B-NP	O	Other	No	No	Other	Other	###	23	phosphodiesterase	phosphodiesterase	NN	NN	_	24	compound	_	_
inhibitors	NNS	I-NP	O	Other	No	No	Other	Other	###	24	inhibitors	inhibitors	NNS	NNS	_	21	nmod	_	_
can	MD	B-VP	O	Other	No	No	Other	Other	###	25	can	can	MD	MD	_	27	aux	_	_
markedly	RB	I-VP	O	Other	No	No	Other	Other	###	26	markedly	markedly	RB	RB	_	27	advmod	_	_
decrease	VB	I-VP	O	Other	No	No	Other	B-Negative_regulation	###	27	decrease	decrease	VB	VB	_	12	conj	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	28	TNF-alpha	TNF-alpha	NN	NN	_	29	compound	_	_
levels.18-19	NN	I-NP	O	Other	No	No	Other	Other	###	29	levels.18-19	levels.18-19	NN	NN	_	27	dobj	_	_
In	IN	B-PP	O	Other	No	No	Other	Other	###	30	In	In	IN	IN	_	34	case	_	_
this	DT	B-NP	O	Other	No	No	Other	Other	###	31	this	this	DT	DT	_	34	det	_	_
in	FW	I-NP	O	Other	No	No	Other	Other	###	32	in	in	FW	FW	_	34	amod	_	_
vitro	FW	I-NP	O	Other	No	No	Other	Other	###	33	vitro	vitro	FW	FW	_	32	dep	_	_
study	NN	I-NP	O	Other	No	No	Other	Other	###	34	study	study	NN	NN	_	27	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	35	,	,	,	,	_	37	punct	_	_
we	PRP	B-NP	O	Other	No	No	Other	Other	###	36	we	we	PRP	PRP	_	37	nsubj	_	_
verified	VBD	B-VP	O	Other	No	No	Other	Other	###	37	verified	verified	VBD	VBD	_	12	conj	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	38	the	the	DT	DT	_	40	det	_	_
sustained	JJ	I-NP	O	Other	No	No	Other	Other	###	39	sustained	sustained	JJ	JJ	_	40	amod	_	_
attenuation	NN	I-NP	O	Other	No	No	Other	B-Negative_regulation	###	40	attenuation	attenuation	NN	NN	_	37	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	41	of	of	IN	IN	_	46	case	_	_
LPS	JJ	B-NP	O	Other	No	No	Other	Other	###	42	LPS	LPS	JJ	JJ	_	46	compound	_	_
-	-	O	O	Other	No	No	Other	Other	###	43	-	-	-	-	_	42	punct	_	_
induced	JJ	B-NP	O	Other	No	No	Other	B-Positive_regulation	###	44	induced	induced	JJ	JJ	_	46	amod	_	_
TNF-alpha	NN	I-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	45	TNF-alpha	TNF-alpha	NN	NN	_	46	compound	_	_
expression	NN	I-NP	O	Other	No	No	Other	B-Gene_expression	###	46	expression	expression	NN	NN	_	40	nmod	_	_
over	IN	B-PP	O	Other	No	No	Other	Other	###	47	over	over	IN	IN	_	48	case	_	_
time	NN	B-NP	O	Other	No	No	Other	Other	###	48	time	time	NN	NN	_	46	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	49	in	in	IN	IN	_	55	case	_	_
an	DT	B-NP	O	Other	No	No	Other	Other	###	50	an	an	DT	DT	_	55	det	_	_
isolated	VBN	I-NP	O	Other	No	No	Other	Other	###	51	isolated	isolated	VBN	VBN	_	55	amod	_	_
human	JJ	I-NP	O	Other	No	No	Other	Other	###	52	human	human	JJ	JJ	_	55	amod	_	_
mononuclear	JJ	I-NP	O	Other	No	No	Other	Other	###	53	mononuclear	mononuclear	JJ	JJ	_	55	amod	_	_
cell	NN	I-NP	O	Other	No	No	Other	Other	###	54	cell	cell	NN	NN	_	55	compound	_	_
population	NN	I-NP	O	Other	No	No	Other	Other	###	55	population	population	NN	NN	_	40	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	56	.	.	.	.	_	4	punct	_	_

The	DT	B-NP	O	Other	No	No	Other	Other	###	1	The	The	DT	DT	_	2	det	_	_
mechanisms	NNS	I-NP	O	Other	No	No	Other	Other	###	2	mechanisms	mechanisms	NNS	NNS	_	24	nsubjpass	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	3	by	by	IN	IN	_	4	case	_	_
which	WDT	B-NP	O	Other	No	No	Other	Other	###	4	which	which	WDT	WDT	_	17	nmod	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	5	PTX	PTX	NN	NN	_	17	nsubj	_	_
,	,	O	O	Other	No	No	Other	Other	###	6	,	,	,	,	_	5	punct	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	7	a	a	DT	DT	_	12	det	_	_
non	JJ	I-NP	O	Other	No	No	Other	Other	###	8	non	non	JJ	JJ	_	12	amod	_	_
-	-	O	O	Other	No	No	Other	Other	###	9	-	-	-	-	_	10	punct	_	_
specific	JJ	I-NP	O	Other	No	No	Other	Other	###	10	specific	specific	JJ	JJ	_	12	amod	_	_
phosphodiesterase	NN	I-NP	O	Other	No	No	Other	Other	###	11	phosphodiesterase	phosphodiesterase	NN	NN	_	12	compound	_	_
inhibitor	NN	I-NP	O	Other	No	No	Other	Other	###	12	inhibitor	inhibitor	NN	NN	_	5	appos	_	_
,	,	O	O	Other	No	No	Other	Other	###	13	,	,	,	,	_	5	punct	_	_
significantly	RB	B-ADVP	O	Other	No	No	Other	Other	###	14	significantly	significantly	RB	RB	_	15	advmod	_	_
and	CC	I-ADVP	O	Other	No	No	Other	Other	###	15	and	and	CC	CC	_	17	advmod	_	_
consistently	RB	B-VP	O	Other	No	No	Other	Other	###	16	consistently	consistently	RB	RB	_	15	advmod	_	_
decreases	VBZ	I-VP	O	Other	No	No	Other	B-Negative_regulation	###	17	decreases	decreases	VBZ	VBZ	_	2	acl:relcl	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	18	TNF-alpha	TNF-alpha	NN	NN	_	19	compound	_	_
production	NN	I-NP	O	Other	No	Yes	Other	B-Gene_expression	###	19	production	production	NN	NN	_	17	dobj	_	_
have	VBP	B-VP	O	Other	No	No	Other	Other	###	20	have	have	VBP	VBP	_	24	aux	_	_
not	RB	I-VP	O	Other	No	No	Other	Other	###	21	not	not	RB	RB	_	24	neg	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	22	been	been	VBN	VBN	_	24	auxpass	_	_
completely	RB	B-ADJP	O	Other	No	No	Other	Other	###	23	completely	completely	RB	RB	_	24	advmod	_	_
elucidated	VBN	I-ADJP	O	Other	No	No	Other	Other	###	24	elucidated	elucidated	VBN	VBN	_	0	root	_	_
.	.	O	O	Other	No	No	Other	Other	###	25	.	.	.	.	_	24	punct	_	_

It	PRP	B-NP	O	Other	No	No	Other	Other	###	1	It	It	PRP	PRP	_	4	nsubjpass	_	_
has	VBZ	B-VP	O	Other	No	No	Other	Other	###	2	has	has	VBZ	VBZ	_	4	aux	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	3	been	been	VBN	VBN	_	4	auxpass	_	_
postulated	VBN	I-VP	O	Other	No	No	Other	Other	###	4	postulated	postulated	VBN	VBN	_	0	root	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	5	that	that	IN	IN	_	11	mark	_	_
drugs	NNS	B-NP	O	Other	No	No	Other	Other	###	6	drugs	drugs	NNS	NNS	_	11	nsubj	_	_
that	WDT	B-NP	O	Other	No	No	Other	Other	###	7	that	that	WDT	WDT	_	8	nsubj	_	_
increase	VBP	B-VP	O	Other	No	Yes	Other	Other	###	8	increase	increase	VBP	VBP	_	6	acl:relcl	_	_
intracellular	JJ	B-NP	O	Other	No	No	Other	Other	###	9	intracellular	intracellular	JJ	JJ	_	10	amod	_	_
cAMP	NN	I-NP	O	Other	No	No	Other	Other	###	10	cAMP	cAMP	NN	NN	_	8	dobj	_	_
exert	VBP	B-VP	O	Other	No	No	Other	Other	###	11	exert	exert	VBP	VBP	_	4	ccomp	_	_
their	PRP$	B-NP	O	Other	No	No	Other	Other	###	12	their	their	PRP$	PRP$	_	14	nmod:poss	_	_
anti-inflammatory	JJ	I-NP	O	Other	No	No	Other	Other	###	13	anti-inflammatory	anti-inflammatory	JJ	JJ	_	14	amod	_	_
effects	NNS	I-NP	O	Other	No	No	Other	Other	###	14	effects	effects	NNS	NNS	_	11	dobj	_	_
through	IN	B-PP	O	Other	No	No	Other	Other	###	15	through	through	IN	IN	_	17	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	16	the	the	DT	DT	_	17	det	_	_
activation	NN	I-NP	O	Other	No	No	Other	Other	###	17	activation	activation	NN	NN	_	11	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	18	of	of	IN	IN	_	19	case	_	_
PKA	NN	B-NP	B-protein	Other	No	No	Other	Other	###	19	PKA	PKA	NN	NN	_	17	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	20	.	.	.	.	_	4	punct	_	_

This	DT	B-NP	O	Other	No	No	Other	Other	###	1	This	This	DT	DT	_	3	det	_	_
classic	JJ	I-NP	O	Other	No	No	Other	Other	###	2	classic	classic	JJ	JJ	_	3	amod	_	_
pathway	NN	I-NP	O	Other	No	No	Other	Other	###	3	pathway	pathway	NN	NN	_	6	nsubjpass	_	_
has	VBZ	B-VP	O	Other	No	No	Other	Other	###	4	has	has	VBZ	VBZ	_	6	aux	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	5	been	been	VBN	VBN	_	6	auxpass	_	_
challenged	VBN	I-VP	O	Other	No	No	Other	Other	###	6	challenged	challenged	VBN	VBN	_	0	root	_	_
as	IN	B-PP	O	Other	No	No	Other	Other	###	7	as	as	IN	IN	_	10	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	8	the	the	DT	DT	_	10	det	_	_
sole	JJ	I-NP	O	Other	No	No	Other	Other	###	9	sole	sole	JJ	JJ	_	10	amod	_	_
mechanism	NN	I-NP	O	Other	No	No	Other	Other	###	10	mechanism	mechanism	NN	NN	_	6	nmod	_	_
involved	VBN	B-VP	O	Other	No	No	Other	Other	###	11	involved	involved	VBN	VBN	_	10	acl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	12	in	in	IN	IN	_	14	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	13	the	the	DT	DT	_	14	det	_	_
modulation	NN	I-NP	O	Other	No	No	Other	Other	###	14	modulation	modulation	NN	NN	_	11	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	15	of	of	IN	IN	_	16	case	_	_
inflammation	NN	B-NP	O	Other	No	No	Other	Other	###	16	inflammation	inflammation	NN	NN	_	14	nmod	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	17	by	by	IN	IN	_	19	case	_	_
cAMP-enhancing	NN	B-NP	O	Other	No	No	Other	Other	###	18	cAMP-enhancing	cAMP-enhancing	NN	NN	_	19	compound	_	_
drugs	NNS	I-NP	O	Other	No	No	Other	Other	###	19	drugs	drugs	NNS	NNS	_	14	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	20	,	,	,	,	_	6	punct	_	_
and	CC	O	O	Other	No	No	Other	Other	###	21	and	and	CC	CC	_	6	cc	_	_
alternative	JJ	B-NP	O	Other	No	No	Other	Other	###	22	alternative	alternative	JJ	JJ	_	23	amod	_	_
mechanisms	NNS	I-NP	O	Other	No	No	Other	Other	###	23	mechanisms	mechanisms	NNS	NNS	_	31	nsubj	_	_
involving	VBG	B-VP	O	Other	No	No	Other	Other	###	24	involving	involving	VBG	VBG	_	23	acl	_	_
PKA	JJ	B-NP	O	Other	No	No	Other	Other	###	25	PKA	PKA	JJ	JJ	_	28	compound	_	_
-	-	O	O	Other	No	No	Other	Other	###	26	-	-	-	-	_	28	punct	_	_
independent	JJ	B-NP	O	Other	No	No	Other	Other	###	27	independent	independent	JJ	JJ	_	25	dep	_	_
pathways	NNS	I-NP	O	Other	No	No	Other	Other	###	28	pathways	pathways	NNS	NNS	_	24	dobj	_	_
have	VBP	B-VP	O	Other	No	No	Other	Other	###	29	have	have	VBP	VBP	_	31	aux	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	30	been	been	VBN	VBN	_	31	cop	_	_
proposed.6-8	JJ	B-ADJP	O	Other	No	No	Other	Other	###	31	proposed.6-8	proposed.6-8	JJ	JJ	_	6	conj	_	_
In	IN	B-PP	O	Other	No	No	Other	Other	###	32	In	In	IN	IN	_	34	case	_	_
this	DT	B-NP	O	Other	No	No	Other	Other	###	33	this	this	DT	DT	_	34	det	_	_
series	NN	I-NP	O	Other	No	No	Other	Other	###	34	series	series	NN	NN	_	31	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	35	of	of	IN	IN	_	36	case	_	_
experiments	NNS	B-NP	O	Other	No	No	Other	Other	###	36	experiments	experiments	NNS	NNS	_	34	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	37	,	,	,	,	_	39	punct	_	_
we	PRP	B-NP	O	Other	No	No	Other	Other	###	38	we	we	PRP	PRP	_	39	nsubj	_	_
observed	VBD	B-VP	O	Other	No	No	Other	Other	###	39	observed	observed	VBD	VBD	_	6	conj	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	40	a	a	DT	DT	_	42	det	_	_
significant	JJ	I-NP	O	Other	No	No	Other	Other	###	41	significant	significant	JJ	JJ	_	42	amod	_	_
attenuation	NN	I-NP	O	Other	No	Yes	Other	B-Negative_regulation	###	42	attenuation	attenuation	NN	NN	_	39	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	43	of	of	IN	IN	_	45	case	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	44	TNF-alpha	TNF-alpha	NN	NN	_	45	compound	_	_
production	NN	I-NP	O	Other	No	Yes	Other	B-Gene_expression	###	45	production	production	NN	NN	_	42	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	46	in	in	IN	IN	_	52	case	_	_
LPS	JJ	B-NP	B-cell_line	Other	No	No	Other	Other	###	47	LPS	LPS	JJ	JJ	_	52	compound	_	_
-	-	O	O	Other	No	No	Other	Other	###	48	-	-	-	-	_	52	punct	_	_
stimulated	JJ	B-NP	B-cell_line	Other	No	No	Other	Other	###	49	stimulated	stimulated	JJ	JJ	_	52	amod	_	_
human	JJ	I-NP	I-cell_line	Other	No	No	Other	Other	###	50	human	human	JJ	JJ	_	52	amod	_	_
mononuclear	JJ	I-NP	I-cell_line	Other	No	No	Other	Other	###	51	mononuclear	mononuclear	JJ	JJ	_	52	amod	_	_
cells	NNS	I-NP	I-cell_line	Other	No	No	Other	Other	###	52	cells	cells	NNS	NNS	_	45	nmod	_	_
following	VBG	B-PP	O	Other	No	Yes	Other	B-Positive_regulation	###	53	following	following	VBG	VBG	_	55	case	_	_
PTX	NN	B-NP	O	Other	No	No	Other	Other	###	54	PTX	PTX	NN	NN	_	55	compound	_	_
administration	NN	I-NP	O	Other	No	No	Other	Other	###	55	administration	administration	NN	NN	_	52	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	56	,	,	,	,	_	55	punct	_	_
independent	JJ	B-ADJP	O	Other	No	No	Other	B-Regulation	###	57	independent	independent	JJ	JJ	_	55	amod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	58	of	of	IN	IN	_	60	case	_	_
PKA	NN	B-NP	B-protein	Other	No	No	Other	Other	###	59	PKA	PKA	NN	NN	_	60	compound	_	_
activation	NN	I-NP	O	Other	No	No	Other	Other	###	60	activation	activation	NN	NN	_	57	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	61	.	.	.	.	_	6	punct	_	_

We	PRP	B-NP	O	Other	No	No	Other	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
used	VBD	B-VP	O	Other	No	No	Other	Other	###	2	used	used	VBD	VBD	_	0	root	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	3	a	a	DT	DT	_	6	det	_	_
nonspecific	JJ	I-NP	O	Other	No	No	Other	Other	###	4	nonspecific	nonspecific	JJ	JJ	_	6	amod	_	_
phosphodiesterase	NN	I-NP	O	Other	No	No	Other	Other	###	5	phosphodiesterase	phosphodiesterase	NN	NN	_	6	compound	_	_
inhibitor	NN	I-NP	O	Other	No	No	Other	Other	###	6	inhibitor	inhibitor	NN	NN	_	2	dobj	_	_
,	,	O	O	Other	No	No	Other	Other	###	7	,	,	,	,	_	6	punct	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	8	PTX	PTX	NN	NN	_	6	appos	_	_
,	,	O	O	Other	No	No	Other	Other	###	9	,	,	,	,	_	6	punct	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	10	in	in	IN	IN	_	13	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	11	the	the	DT	DT	_	13	det	_	_
present	JJ	I-NP	O	Other	No	No	Other	Other	###	12	present	present	JJ	JJ	_	13	amod	_	_
study	NN	I-NP	O	Other	No	No	Other	Other	###	13	study	study	NN	NN	_	2	nmod	_	_
because	IN	B-SBAR	O	Other	No	No	Other	Other	###	14	because	because	IN	IN	_	18	mark	_	_
it	PRP	B-NP	O	Other	No	No	Other	Other	###	15	it	it	PRP	PRP	_	18	nsubjpass	_	_
has	VBZ	B-VP	O	Other	No	No	Other	Other	###	16	has	has	VBZ	VBZ	_	18	aux	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	17	been	been	VBN	VBN	_	18	auxpass	_	_
used	VBN	I-VP	O	Other	No	No	Other	Other	###	18	used	used	VBN	VBN	_	2	advcl	_	_
clinically	RB	B-ADVP	O	Other	No	No	Other	Other	###	19	clinically	clinically	RB	RB	_	18	advmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	20	in	in	IN	IN	_	22	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	21	the	the	DT	DT	_	22	det	_	_
treatment	NN	I-NP	O	Other	No	No	Other	Other	###	22	treatment	treatment	NN	NN	_	18	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	23	of	of	IN	IN	_	25	case	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	24	a	a	DT	DT	_	25	det	_	_
variety	NN	I-NP	O	Other	No	No	Other	Other	###	25	variety	variety	NN	NN	_	22	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	26	of	of	IN	IN	_	27	case	_	_
conditions	NNS	B-NP	O	Other	No	No	Other	Other	###	27	conditions	conditions	NNS	NNS	_	25	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	28	in	in	IN	IN	_	29	case	_	_
which	WDT	B-NP	O	Other	No	No	Other	Other	###	29	which	which	WDT	WDT	_	34	nmod	_	_
inflammation	NN	B-NP	O	Other	No	No	Other	Other	###	30	inflammation	inflammation	NN	NN	_	34	nsubj	_	_
is	VBZ	B-VP	O	Other	No	No	Other	Other	###	31	is	is	VBZ	VBZ	_	34	cop	_	_
an	DT	B-NP	O	Other	No	No	Other	Other	###	32	an	an	DT	DT	_	34	det	_	_
important	JJ	I-NP	O	Other	No	No	Other	Other	###	33	important	important	JJ	JJ	_	34	amod	_	_
component	NN	I-NP	O	Other	No	No	Other	Other	###	34	component	component	NN	NN	_	27	acl:relcl	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	35	of	of	IN	IN	_	37	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	36	the	the	DT	DT	_	37	det	_	_
pathophysiology	NN	I-NP	O	Other	No	No	Other	Other	###	37	pathophysiology	pathophysiology	NN	NN	_	34	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	38	of	of	IN	IN	_	41	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	39	the	the	DT	DT	_	41	det	_	_
disease	NN	I-NP	O	Other	No	No	Other	Other	###	40	disease	disease	NN	NN	_	41	compound	_	_
process.19	NN	I-NP	O	Other	No	No	Other	Other	###	41	process.19	process.19	NN	NN	_	37	nmod	_	_
Additionally	RB	B-ADVP	O	Other	No	No	Other	Other	###	42	Additionally	Additionally	RB	RB	_	34	advmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	43	,	,	,	,	_	63	punct	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	44	the	the	DT	DT	_	45	det	_	_
use	NN	I-NP	O	Other	No	No	Other	Other	###	45	use	use	NN	NN	_	63	nsubjpass	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	46	of	of	IN	IN	_	47	case	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	47	PTX	PTX	NN	NN	_	45	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	48	in	in	IN	IN	_	49	case	_	_
sepsis	NN	B-NP	O	Other	No	No	Other	Other	###	49	sepsis	sepsis	NN	NN	_	45	nmod	_	_
as	IN	B-PP	O	Other	No	No	Other	Other	###	50	as	as	IN	IN	_	52	case	_	_
an	DT	B-NP	O	Other	No	No	Other	Other	###	51	an	an	DT	DT	_	52	det	_	_
adjunct	JJ	I-NP	O	Other	No	No	Other	Other	###	52	adjunct	adjunct	JJ	JJ	_	45	nmod	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	53	to	to	TO	TO	_	54	case	_	_
other	JJ	B-NP	O	Other	No	No	Other	Other	###	54	other	other	JJ	JJ	_	55	amod	_	_
treatments	NNS	I-NP	O	Other	No	No	Other	Other	###	55	treatments	treatments	NNS	NNS	_	52	nmod	_	_
to	TO	B-VP	O	Other	No	No	Other	Other	###	56	to	to	TO	TO	_	57	mark	_	_
maintain	VB	I-VP	O	Other	No	No	Other	Other	###	57	maintain	maintain	VB	VB	_	55	acl	_	_
adequate	JJ	B-NP	O	Other	No	No	Other	Other	###	58	adequate	adequate	JJ	JJ	_	60	amod	_	_
organ	NN	I-NP	O	Other	No	No	Other	Other	###	59	organ	organ	NN	NN	_	60	compound	_	_
function	NN	I-NP	O	Other	No	No	Other	Other	###	60	function	function	NN	NN	_	57	dobj	_	_
has	VBZ	B-VP	O	Other	No	No	Other	Other	###	61	has	has	VBZ	VBZ	_	63	aux	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	62	been	been	VBN	VBN	_	63	auxpass	_	_
explored	VBN	I-VP	O	Other	No	No	Other	Other	###	63	explored	explored	VBN	VBN	_	2	parataxis	_	_
based	VBN	I-VP	O	Other	No	No	Other	Other	###	64	based	based	VBN	VBN	_	63	advcl	_	_
upon	IN	B-PP	O	Other	No	No	Other	Other	###	65	upon	upon	IN	IN	_	67	case	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	66	its	its	PRP$	PRP$	_	67	nmod:poss	_	_
effects	NNS	I-NP	O	Other	No	No	Other	B-Regulation	###	67	effects	effects	NNS	NNS	_	64	nmod	_	_
on	IN	B-PP	O	Other	No	No	Other	Other	###	68	on	on	IN	IN	_	70	case	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	69	TNF-alpha	TNF-alpha	NN	NN	_	70	compound	_	_
synthesis	NN	I-NP	O	Other	No	Yes	Other	B-Gene_expression	###	70	synthesis	synthesis	NN	NN	_	67	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	71	.	.	.	.	_	2	punct	_	_

However	RB	B-ADVP	O	Other	No	No	Other	Other	###	1	However	However	RB	RB	_	12	advmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	2	,	,	,	,	_	12	punct	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	3	the	the	DT	DT	_	6	det	_	_
reported	VBN	I-NP	O	Other	No	No	Other	Other	###	4	reported	reported	VBN	VBN	_	6	amod	_	_
beneficial	JJ	I-NP	O	Other	No	No	Other	Other	###	5	beneficial	beneficial	JJ	JJ	_	6	amod	_	_
effects	NNS	I-NP	O	Other	No	Yes	Other	Other	###	6	effects	effects	NNS	NNS	_	12	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	7	of	of	IN	IN	_	8	case	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	8	PTX	PTX	NN	NN	_	6	nmod	_	_
are	VBP	B-VP	O	Other	No	No	Other	Other	###	9	are	are	VBP	VBP	_	12	cop	_	_
not	RB	B-CONJP	O	Other	No	No	Other	Other	###	10	not	not	RB	RB	_	11	neg	_	_
only	RB	I-CONJP	O	Other	No	No	Other	Other	###	11	only	only	RB	RB	_	12	dep	_	_
related	JJ	B-ADJP	O	Other	No	No	Other	Other	###	12	related	related	JJ	JJ	_	0	root	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	13	to	to	TO	TO	_	15	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	14	the	the	DT	DT	_	15	det	_	_
downregulation	NN	I-NP	O	Other	No	No	Other	B-Negative_regulation	###	15	downregulation	downregulation	NN	NN	_	12	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	16	of	of	IN	IN	_	17	case	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	17	TNF-alpha	TNF-alpha	NN	NN	_	15	nmod	_	_
but	NN	B-NP	O	Other	No	No	Other	Other	###	18	but	but	NN	NN	_	15	cc	_	_
also	RB	B-ADVP	O	Other	No	No	Other	Other	###	19	also	also	RB	RB	_	24	advmod	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	20	to	to	TO	TO	_	24	case	_	_
PTX	NN	B-NP	O	Other	No	No	Other	Other	###	21	PTX	PTX	NN	NN	_	24	nmod:poss	_	_
's	POS	B-NP	O	Other	No	No	Other	Other	###	22	's	's	POS	POS	_	21	case	_	_
hemorrheologic	JJ	I-NP	O	Other	No	No	Other	Other	###	23	hemorrheologic	hemorrheologic	JJ	JJ	_	24	amod	_	_
properties	NNS	I-NP	O	Other	No	No	Other	Other	###	24	properties	properties	NNS	NNS	_	15	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	25	,	,	,	,	_	15	punct	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	26	its	its	PRP$	PRP$	_	27	nmod:poss	_	_
ability	NN	I-NP	O	Other	No	No	Other	Other	###	27	ability	ability	NN	NN	_	15	conj	_	_
to	TO	B-VP	O	Other	No	No	Other	Other	###	28	to	to	TO	TO	_	29	mark	_	_
reduce	VB	I-VP	O	Other	No	No	Other	Other	###	29	reduce	reduce	VB	VB	_	27	acl	_	_
neutrophil	NN	B-NP	B-cell_type	Other	No	No	Other	Other	###	30	neutrophil	neutrophil	NN	NN	_	31	compound	_	_
activation	NN	I-NP	O	Other	No	No	Other	Other	###	31	activation	activation	NN	NN	_	29	dobj	_	_
,	,	O	O	Other	No	No	Other	Other	###	32	,	,	,	,	_	15	punct	_	_
and	CC	O	O	Other	No	No	Other	Other	###	33	and	and	CC	CC	_	15	cc	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	34	its	its	PRP$	PRP$	_	36	nmod:poss	_	_
beneficial	JJ	I-NP	O	Other	No	No	Other	Other	###	35	beneficial	beneficial	JJ	JJ	_	36	amod	_	_
effects	NNS	I-NP	O	Other	No	Yes	Other	Other	###	36	effects	effects	NNS	NNS	_	15	conj	_	_
on	IN	B-PP	O	Other	No	No	Other	Other	###	37	on	on	IN	IN	_	38	case	_	_
microcirculation	NN	B-NP	O	Other	No	No	Other	Other	###	38	microcirculation	microcirculation	NN	NN	_	36	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	39	,	,	,	,	_	38	punct	_	_
cardiac	JJ	B-NP	O	Other	No	No	Other	Other	###	40	cardiac	cardiac	JJ	JJ	_	41	amod	_	_
performance	NN	I-NP	O	Other	No	No	Other	Other	###	41	performance	performance	NN	NN	_	38	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	42	,	,	,	,	_	38	punct	_	_
and	CC	O	O	Other	No	No	Other	Other	###	43	and	and	CC	CC	_	38	cc	_	_
organ	NN	B-NP	O	Other	No	No	Other	Other	###	44	organ	organ	NN	NN	_	45	compound	_	_
injury.20-25	NN	I-NP	O	Other	No	No	Other	Other	###	45	injury.20-25	injury.20-25	NN	NN	_	38	conj	_	_
Herein	RB	B-ADVP	O	Other	No	No	Other	Other	###	46	Herein	Herein	RB	RB	_	45	advmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	47	,	,	,	,	_	49	punct	_	_
we	PRP	B-NP	O	Other	No	No	Other	Other	###	48	we	we	PRP	PRP	_	49	nsubj	_	_
demonstrated	VBD	B-VP	O	Other	No	No	Other	Other	###	49	demonstrated	demonstrated	VBD	VBD	_	12	parataxis	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	50	that	that	IN	IN	_	60	mark	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	51	the	the	DT	DT	_	53	det	_	_
downregulatory	JJ	I-NP	O	Other	No	No	Other	Other	###	52	downregulatory	downregulatory	JJ	JJ	_	53	amod	_	_
effects	NNS	I-NP	O	Other	No	Yes	Other	Other	###	53	effects	effects	NNS	NNS	_	60	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	54	of	of	IN	IN	_	55	case	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	55	PTX	PTX	NN	NN	_	53	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	56	in	in	IN	IN	_	59	case	_	_
human	JJ	B-NP	B-cell_type	Other	No	No	Other	Other	###	57	human	human	JJ	JJ	_	59	amod	_	_
mononuclear	JJ	I-NP	I-cell_type	Other	No	No	Other	Other	###	58	mononuclear	mononuclear	JJ	JJ	_	59	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	No	No	Other	Other	###	59	cells	cells	NNS	NNS	_	53	nmod	_	_
involves	VBZ	B-VP	O	Other	No	No	Other	Other	###	60	involves	involves	VBZ	VBZ	_	49	ccomp	_	_
modulation	NN	B-NP	O	Other	No	No	Other	Other	###	61	modulation	modulation	NN	NN	_	60	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	62	of	of	IN	IN	_	63	case	_	_
pathways	NNS	B-NP	O	Other	No	No	Other	Other	###	63	pathways	pathways	NNS	NNS	_	61	nmod	_	_
that	WDT	B-NP	O	Other	No	No	Other	Other	###	64	that	that	WDT	WDT	_	65	nsubj	_	_
involve	VBP	B-VP	O	Other	No	No	Other	Other	###	65	involve	involve	VBP	VBP	_	63	acl:relcl	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	66	NF-kappaB	NF-kappaB	NN	NN	_	65	dobj	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	67	and	and	CC	CC	_	66	cc	_	_
CREB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	68	CREB	CREB	NN	NN	_	66	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	69	,	,	,	,	_	66	punct	_	_
two	CD	B-NP	O	Other	No	No	Other	Other	###	70	two	two	CD	CD	_	73	nummod	_	_
major	JJ	I-NP	O	Other	No	No	Other	Other	###	71	major	major	JJ	JJ	_	73	amod	_	_
transcription	NN	I-NP	B-protein	Other	No	No	Other	Other	###	72	transcription	transcription	NN	NN	_	73	compound	_	_
factors	NNS	I-NP	I-protein	Other	No	No	Other	Other	###	73	factors	factors	NNS	NNS	_	66	appos	_	_
involved	VBN	B-VP	O	Other	No	No	Other	Other	###	74	involved	involved	VBN	VBN	_	73	acl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	75	in	in	IN	IN	_	78	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	76	the	the	DT	DT	_	78	det	_	_
inflammatory	JJ	I-NP	O	Other	No	No	Other	Other	###	77	inflammatory	inflammatory	JJ	JJ	_	78	amod	_	_
cascade	NN	I-NP	O	Other	No	No	Other	Other	###	78	cascade	cascade	NN	NN	_	74	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	79	.	.	.	.	_	49	punct	_	_

NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	1	NF-kappaB	NF-kappaB	NN	NN	_	3	compound	_	_
/	/	O	O	Other	No	No	Other	Other	###	2	/	/	/	/	_	3	punct	_	_
Rel	NN	B-NP	B-protein	Other	No	No	Other	Other	###	3	Rel	Rel	NN	NN	_	4	nsubj	_	_
constitutes	VBZ	B-VP	O	Other	No	No	Other	Other	###	4	constitutes	constitutes	VBZ	VBZ	_	0	root	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	5	a	a	DT	DT	_	6	det	_	_
family	NN	I-NP	O	Other	No	No	Other	Other	###	6	family	family	NN	NN	_	4	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	7	of	of	IN	IN	_	9	case	_	_
transcriptional	JJ	B-NP	B-protein	Other	No	No	Other	Other	###	8	transcriptional	transcriptional	JJ	JJ	_	9	amod	_	_
factors	NNS	I-NP	I-protein	Other	No	No	Other	Other	###	9	factors	factors	NNS	NNS	_	6	nmod	_	_
involved	VBN	B-VP	O	Other	No	No	Other	Other	###	10	involved	involved	VBN	VBN	_	9	acl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	11	in	in	IN	IN	_	13	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	12	the	the	DT	DT	_	13	det	_	_
regulation	NN	I-NP	O	Other	No	No	Other	Other	###	13	regulation	regulation	NN	NN	_	10	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	14	of	of	IN	IN	_	17	case	_	_
numerous	JJ	B-NP	O	Other	No	No	Other	Other	###	15	numerous	numerous	JJ	JJ	_	17	amod	_	_
cytokine	NN	I-NP	B-DNA	Other	No	No	Other	Other	###	16	cytokine	cytokine	NN	NN	_	17	compound	_	_
genes	NNS	I-NP	I-DNA	Other	No	No	Other	Other	###	17	genes	genes	NNS	NNS	_	13	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	18	and	and	CC	CC	_	17	cc	_	_
immune	JJ	B-NP	O	Other	No	No	Other	Other	###	19	immune	immune	JJ	JJ	_	20	amod	_	_
responses	NNS	I-NP	O	Other	No	No	Other	Other	###	20	responses	responses	NNS	NNS	_	13	conj	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	21	in	in	IN	IN	_	24	case	_	_
different	JJ	B-NP	O	Other	No	No	Other	Other	###	22	different	different	JJ	JJ	_	24	amod	_	_
cell	NN	I-NP	O	Other	No	No	Other	Other	###	23	cell	cell	NN	NN	_	24	compound	_	_
populations	NNS	I-NP	O	Other	No	No	Other	Other	###	24	populations	populations	NNS	NNS	_	13	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	25	.	.	.	.	_	4	punct	_	_

The	DT	B-NP	O	Other	No	No	Other	Other	###	1	The	The	DT	DT	_	4	det	_	_
most	RBS	I-NP	O	Other	No	No	Other	Other	###	2	most	most	RBS	RBS	_	3	advmod	_	_
abundant	JJ	I-NP	O	Other	No	No	Other	Other	###	3	abundant	abundant	JJ	JJ	_	4	amod	_	_
form	NN	I-NP	O	Other	No	No	Other	Other	###	4	form	form	NN	NN	_	18	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	5	of	of	IN	IN	_	6	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	6	NF-kappaB	NF-kappaB	NN	NN	_	4	nmod	_	_
is	VBZ	B-VP	O	Other	No	No	Other	Other	###	7	is	is	VBZ	VBZ	_	12	cop	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	8	the	the	DT	DT	_	12	det	_	_
p50	NN	B-NP	B-protein	B-Protein	No	No	Other	Other	###	9	p50	p50	NN	NN	_	12	compound	_	_
-	-	O	O	Other	No	No	Other	Other	###	10	-	-	-	-	_	12	punct	_	_
p65	NN	B-NP	O	B-Protein	No	No	Other	Other	###	11	p65	p65	NN	NN	_	12	compound	_	_
heterodimer.26	NN	I-NP	I-protein	Other	No	No	Other	Other	###	12	heterodimer.26	heterodimer.26	NN	NN	_	0	root	_	_
The	DT	B-NP	I-protein	Other	No	No	Other	Other	###	13	The	The	DT	DT	_	15	det	_	_
inactive	JJ	I-NP	I-protein	Other	No	No	Other	Other	###	14	inactive	inactive	JJ	JJ	_	15	amod	_	_
form	NN	I-NP	I-protein	Other	No	No	Other	Other	###	15	form	form	NN	NN	_	18	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	16	of	of	IN	IN	_	17	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	17	NF-kappaB	NF-kappaB	NN	NN	_	15	nmod	_	_
exists	VBZ	B-VP	O	Other	No	No	Other	Other	###	18	exists	exists	VBZ	VBZ	_	12	parataxis	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	19	in	in	IN	IN	_	21	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	20	the	the	DT	DT	_	21	det	_	_
cytoplasm	NN	I-NP	O	Other	No	No	Other	Other	###	21	cytoplasm	cytoplasm	NN	NN	_	18	nmod	_	_
bound	VBD	B-VP	O	Other	No	No	Other	Other	###	22	bound	bound	VBD	VBD	_	21	acl	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	23	to	to	TO	TO	_	26	case	_	_
an	DT	B-NP	O	Other	No	No	Other	Other	###	24	an	an	DT	DT	_	26	det	_	_
inhibitory	JJ	I-NP	B-protein	Other	No	No	Other	Other	###	25	inhibitory	inhibitory	JJ	JJ	_	26	amod	_	_
complex	NN	I-NP	I-protein	Other	No	No	Other	Other	###	26	complex	complex	NN	NN	_	22	nmod	_	_
containing	VBG	B-VP	O	Other	No	No	Other	Other	###	27	containing	containing	VBG	VBG	_	26	acl	_	_
I-kappaBalpha	NN	B-NP	B-protein	B-Protein	No	No	Other	Other	###	28	I-kappaBalpha	I-kappaBalpha	NN	NN	_	27	dobj	_	_
.	.	O	O	Other	No	No	Other	Other	###	29	.	.	.	.	_	18	punct	_	_

Following	VBG	B-PP	O	Other	No	No	Other	Other	###	1	Following	Following	VBG	VBG	_	3	case	_	_
cellular	JJ	B-NP	O	Other	No	No	Other	Other	###	2	cellular	cellular	JJ	JJ	_	3	amod	_	_
stimulation	NN	I-NP	O	Other	No	No	Other	Other	###	3	stimulation	stimulation	NN	NN	_	13	nmod	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	4	with	with	IN	IN	_	5	case	_	_
LPS	NN	B-NP	O	Other	No	No	Other	Other	###	5	LPS	LPS	NN	NN	_	3	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	6	and	and	CC	CC	_	5	cc	_	_
chemotactic	JJ	B-NP	B-protein	Other	No	No	Other	Other	###	7	chemotactic	chemotactic	JJ	JJ	_	8	amod	_	_
factors	NNS	I-NP	I-protein	Other	No	No	Other	Other	###	8	factors	factors	NNS	NNS	_	5	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	9	,	,	,	,	_	13	punct	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	10	NF-kappaB	NF-kappaB	NN	NN	_	12	compound	_	_
inducible	JJ	I-NP	O	Other	No	No	Other	Other	###	11	inducible	inducible	JJ	JJ	_	12	amod	_	_
kinase	NN	I-NP	O	Other	No	No	Other	Other	###	12	kinase	kinase	NN	NN	_	13	nsubj	_	_
phosphorylates	VBZ	B-VP	O	Other	No	No	Other	Other	###	13	phosphorylates	phosphorylates	VBZ	VBZ	_	0	root	_	_
and	CC	I-VP	O	Other	No	No	Other	Other	###	14	and	and	CC	CC	_	13	cc	_	_
activates	VBZ	I-VP	O	Other	No	No	Other	Other	###	15	activates	activates	VBZ	VBZ	_	13	conj	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	16	the	the	DT	DT	_	22	det	_	_
I-kappaB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	17	I-kappaB	I-kappaB	NN	NN	_	22	compound	_	_
kinase	NN	I-NP	I-protein	Other	No	No	Other	Other	###	18	kinase	kinase	NN	NN	_	22	compound	_	_
(	(	O	O	Other	No	No	Other	Other	###	19	(	(	(	(	_	22	punct	_	_
IKK	NN	B-NP	B-protein	Other	No	No	Other	Other	###	20	IKK	IKK	NN	NN	_	22	compound	_	_
)	)	O	O	Other	No	No	Other	Other	###	21	)	)	)	)	_	22	punct	_	_
complex	NN	B-NP	O	Other	No	No	Other	Other	###	22	complex	complex	NN	NN	_	15	dobj	_	_
consisting	VBG	B-VP	O	Other	No	No	Other	Other	###	23	consisting	consisting	VBG	VBG	_	22	acl	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	24	of	of	IN	IN	_	25	case	_	_
IKK-1	NN	B-NP	B-protein	B-Protein	No	No	Other	Other	###	25	IKK-1	IKK-1	NN	NN	_	23	nmod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	26	and	and	CC	CC	_	25	cc	_	_
IKK-2	NN	I-NP	B-protein	B-Protein	No	No	Other	Other	###	27	IKK-2	IKK-2	NN	NN	_	25	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	28	,	,	,	,	_	25	punct	_	_
which	WDT	B-NP	O	Other	No	No	Other	Other	###	29	which	which	WDT	WDT	_	32	nsubj	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	30	in	in	IN	IN	_	31	case	_	_
turn	NN	B-NP	O	Other	No	No	Other	Other	###	31	turn	turn	NN	NN	_	32	nmod	_	_
phosphorylates	VBZ	B-VP	O	Other	No	No	Other	B-Phosphorylation	###	32	phosphorylates	phosphorylates	VBZ	VBZ	_	25	acl:relcl	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	33	the	the	DT	DT	_	35	det	_	_
I-kappaBalpha	NN	I-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	34	I-kappaBalpha	I-kappaBalpha	NN	NN	_	35	compound	_	_
subunit	NN	I-NP	I-protein	Other	No	No	Other	Other	###	35	subunit	subunit	NN	NN	_	32	dobj	_	_
.	.	O	O	Other	No	No	Other	Other	###	36	.	.	.	.	_	13	punct	_	_

Phosphorylation	NN	B-NP	O	Other	No	No	Other	B-Phosphorylation	###	1	Phosphorylation	Phosphorylation	NN	NN	_	10	nsubj	_	_
,	,	O	O	Other	No	No	Other	Other	###	2	,	,	,	,	_	1	punct	_	_
ubiquitination	NN	B-NP	O	Other	No	No	Other	Other	###	3	ubiquitination	ubiquitination	NN	NN	_	1	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	4	,	,	,	,	_	1	punct	_	_
and	CC	O	O	Other	No	No	Other	Other	###	5	and	and	CC	CC	_	1	cc	_	_
subsequent	JJ	B-NP	O	Other	No	No	Other	Other	###	6	subsequent	subsequent	JJ	JJ	_	7	amod	_	_
degradation	NN	I-NP	O	Other	No	No	Other	B-Protein_catabolism	###	7	degradation	degradation	NN	NN	_	1	conj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	8	of	of	IN	IN	_	9	case	_	_
I-kappaBalpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	9	I-kappaBalpha	I-kappaBalpha	NN	NN	_	1	nmod	_	_
results	VBZ	B-VP	O	Other	No	No	Other	Other	###	10	results	results	VBZ	VBZ	_	0	root	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	11	in	in	IN	IN	_	14	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	12	NF-kappaB	NF-kappaB	NN	NN	_	14	compound	_	_
nuclear	JJ	I-NP	O	Other	No	No	Other	Other	###	13	nuclear	nuclear	JJ	JJ	_	14	amod	_	_
translocation	NN	I-NP	O	Other	No	No	Other	Other	###	14	translocation	translocation	NN	NN	_	10	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	15	.	.	.	.	_	10	punct	_	_

This	DT	B-NP	O	Other	No	No	Other	Other	###	1	This	This	DT	DT	_	2	nsubj	_	_
allows	VBZ	B-VP	O	Other	No	No	Other	Other	###	2	allows	allows	VBZ	VBZ	_	0	root	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	3	the	the	DT	DT	_	5	det	_	_
transcription	NN	I-NP	B-protein	Other	No	No	Other	Other	###	4	transcription	transcription	NN	NN	_	5	compound	_	_
factor	NN	I-NP	I-protein	Other	No	No	Other	Other	###	5	factor	factor	NN	NN	_	2	dobj	_	_
to	TO	B-VP	O	Other	No	No	Other	Other	###	6	to	to	TO	TO	_	7	mark	_	_
bind	VB	I-VP	O	Other	No	No	Other	Other	###	7	bind	bind	VB	VB	_	2	xcomp	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	8	to	to	TO	TO	_	10	case	_	_
promoter	NN	B-NP	B-DNA	Other	No	No	Other	Other	###	9	promoter	promoter	NN	NN	_	10	compound	_	_
regions	NNS	I-NP	I-DNA	Other	No	No	Other	Other	###	10	regions	regions	NNS	NNS	_	7	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	11	of	of	IN	IN	_	14	case	_	_
specific	JJ	B-NP	O	Other	No	No	Other	Other	###	12	specific	specific	JJ	JJ	_	14	amod	_	_
pro-inflammatory	JJ	I-NP	B-DNA	Other	No	No	Other	Other	###	13	pro-inflammatory	pro-inflammatory	JJ	JJ	_	14	amod	_	_
genes	NNS	I-NP	I-DNA	Other	No	No	Other	Other	###	14	genes	genes	NNS	NNS	_	10	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	15	and	and	CC	CC	_	2	cc	_	_
influence	VB	B-VP	O	Other	No	No	Other	Other	###	16	influence	influence	VB	VB	_	2	conj	_	_
transcription.27	NN	B-NP	O	Other	No	No	Other	Other	###	17	transcription.27	transcription.27	NN	NN	_	16	dobj	_	_
,	,	O	O	Other	No	No	Other	Other	###	18	,	,	,	,	_	17	punct	_	_
28	CD	B-NP	O	Other	No	No	Other	Other	###	19	28	28	CD	CD	_	17	appos	_	_
Because	IN	B-SBAR	O	Other	No	No	Other	Other	###	20	Because	Because	IN	IN	_	28	mark	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	21	a	a	DT	DT	_	22	det	_	_
number	NN	I-NP	O	Other	No	No	Other	Other	###	22	number	number	NN	NN	_	28	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	23	of	of	IN	IN	_	26	case	_	_
potential	JJ	B-NP	O	Other	No	No	Other	Other	###	24	potential	potential	JJ	JJ	_	26	amod	_	_
kappaB	NN	I-NP	B-DNA	Other	No	No	Other	Other	###	25	kappaB	kappaB	NN	NN	_	26	compound	_	_
sites	NNS	I-NP	I-DNA	Other	No	No	Other	Other	###	26	sites	sites	NNS	NNS	_	22	nmod	_	_
are	VBP	B-VP	O	Other	No	No	Other	Other	###	27	are	are	VBP	VBP	_	28	cop	_	_
present	JJ	B-ADJP	O	Other	No	No	Other	Other	###	28	present	present	JJ	JJ	_	40	advcl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	29	in	in	IN	IN	_	32	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	30	the	the	DT	DT	_	32	det	_	_
nucleotide	NN	I-NP	B-DNA	Other	No	No	Other	Other	###	31	nucleotide	nucleotide	NN	NN	_	32	compound	_	_
sequences	NNS	I-NP	I-DNA	Other	No	No	Other	Other	###	32	sequences	sequences	NNS	NNS	_	28	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	33	of	of	IN	IN	_	36	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	34	the	the	DT	DT	_	36	det	_	_
TNF-alpha	NN	I-NP	B-DNA	B-Protein	Yes	No	Other	Other	###	35	TNF-alpha	TNF-alpha	NN	NN	_	36	compound	_	_
gene	NN	I-NP	I-DNA	Other	No	No	Other	Other	###	36	gene	gene	NN	NN	_	32	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	37	,	,	,	,	_	40	punct	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	38	NF-kappaB	NF-kappaB	NN	NN	_	40	nsubjpass	_	_
is	VBZ	B-VP	O	Other	No	No	Other	Other	###	39	is	is	VBZ	VBZ	_	40	auxpass	_	_
considered	VBN	I-VP	O	Other	No	No	Other	Other	###	40	considered	considered	VBN	VBN	_	2	conj	_	_
to	TO	I-VP	O	Other	No	No	Other	Other	###	41	to	to	TO	TO	_	46	mark	_	_
be	VB	I-VP	O	Other	No	No	Other	Other	###	42	be	be	VB	VB	_	46	cop	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	43	a	a	DT	DT	_	46	det	_	_
critical	JJ	I-NP	O	Other	No	No	Other	Other	###	44	critical	critical	JJ	JJ	_	46	amod	_	_
transcriptional	JJ	I-NP	B-protein	Other	No	No	Other	Other	###	45	transcriptional	transcriptional	JJ	JJ	_	46	amod	_	_
factor	NN	I-NP	I-protein	Other	No	No	Other	Other	###	46	factor	factor	NN	NN	_	40	xcomp	_	_
involved	VBN	B-VP	O	Other	No	No	Other	B-Regulation	###	47	involved	involved	VBN	VBN	_	46	acl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	48	in	in	IN	IN	_	51	case	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	49	TNF-alpha	TNF-alpha	NN	NN	_	51	compound	_	_
gene	NN	I-NP	O	Other	No	No	Other	B-Gene_expression	###	50	gene	gene	NN	NN	_	51	compound	_	_
expression	NN	I-NP	O	Other	No	Yes	Other	I-Gene_expression	###	51	expression	expression	NN	NN	_	47	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	52	and	and	CC	CC	_	51	cc	_	_
protein	NN	B-NP	O	Other	No	No	Other	Other	###	53	protein	protein	NN	NN	_	54	compound	_	_
synthesis.29	NN	I-NP	O	Other	No	No	Other	Other	###	54	synthesis.29	synthesis.29	NN	NN	_	51	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	55	,	,	,	,	_	40	punct	_	_
30	CD	B-NP	O	Other	No	No	Other	Other	###	56	30	30	CD	CD	_	40	nmod	_	_

In	IN	B-PP	O	Other	No	No	Other	Other	###	1	In	In	IN	IN	_	3	case	_	_
this	DT	B-NP	O	Other	No	No	Other	Other	###	2	this	this	DT	DT	_	3	det	_	_
set	NN	I-NP	O	Other	No	No	Other	Other	###	3	set	set	NN	NN	_	8	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	4	of	of	IN	IN	_	5	case	_	_
experiments	NNS	B-NP	O	Other	No	No	Other	Other	###	5	experiments	experiments	NNS	NNS	_	3	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	6	,	,	,	,	_	8	punct	_	_
we	PRP	B-NP	O	Other	No	No	Other	Other	###	7	we	we	PRP	PRP	_	8	nsubj	_	_
demonstrated	VBD	B-VP	O	Other	No	No	Other	Other	###	8	demonstrated	demonstrated	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	9	that	that	IN	IN	_	11	mark	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	10	PTX	PTX	NN	NN	_	11	nsubj	_	_
downregulates	VBZ	B-VP	O	Other	No	No	Other	B-Negative_regulation	###	11	downregulates	downregulates	VBZ	VBZ	_	8	ccomp	_	_
cytoplasmic	JJ	B-NP	B-protein	Other	No	No	Other	Other	###	12	cytoplasmic	cytoplasmic	JJ	JJ	_	14	amod	_	_
I-kappaBalpha	NN	I-NP	I-protein	B-Protein	Yes	No	B-Protein	Other	###	13	I-kappaBalpha	I-kappaBalpha	NN	NN	_	14	compound	_	_
phosphorylation	NN	I-NP	O	Other	No	No	Other	B-Phosphorylation	###	14	phosphorylation	phosphorylation	NN	NN	_	11	dobj	_	_
,	,	O	O	Other	No	No	Other	Other	###	15	,	,	,	,	_	14	punct	_	_
nuclear	JJ	B-NP	O	Other	No	No	Other	Other	###	16	nuclear	nuclear	JJ	JJ	_	19	amod	_	_
NF-kappaB	NN	I-NP	O	Other	No	No	Other	Other	###	17	NF-kappaB	NF-kappaB	NN	NN	_	19	compound	_	_
p65	NN	I-NP	O	B-Protein	Yes	No	B-Protein	Other	###	18	p65	p65	NN	NN	_	19	compound	_	_
phosphorylation	NN	I-NP	O	Other	No	No	Other	B-Phosphorylation	###	19	phosphorylation	phosphorylation	NN	NN	_	14	conj	_	_
/	/	O	O	Other	No	No	Other	Other	###	20	/	/	/	/	_	14	punct	_	_
translocation	NN	I-NP	O	Other	No	No	Other	B-Localization	###	21	translocation	translocation	NN	NN	_	14	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	22	,	,	,	,	_	14	punct	_	_
as	RB	B-CONJP	O	Other	No	No	Other	Other	###	23	as	as	RB	RB	_	14	cc	_	_
well	RB	I-CONJP	O	Other	No	No	Other	Other	###	24	well	well	RB	RB	_	23	mwe	_	_
as	IN	I-CONJP	O	Other	No	No	Other	Other	###	25	as	as	IN	IN	_	23	mwe	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	26	NF-kappaB	NF-kappaB	NN	NN	_	27	compound	_	_
DNA	JJ	B-ADJP	O	Other	No	No	Other	Other	###	27	DNA	DNA	JJ	JJ	_	29	compound	_	_
-	-	O	O	Other	No	No	Other	Other	###	28	-	-	-	-	_	27	punct	_	_
binding	JJ	B-ADJP	O	Other	No	No	Other	Other	###	29	binding	binding	JJ	JJ	_	14	conj	_	_
after	IN	B-PP	O	Other	No	No	Other	Other	###	30	after	after	IN	IN	_	32	case	_	_
LPS	NN	B-NP	O	Other	No	No	Other	Other	###	31	LPS	LPS	NN	NN	_	32	compound	_	_
stimulation	NN	I-NP	O	Other	No	No	Other	Other	###	32	stimulation	stimulation	NN	NN	_	29	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	33	,	,	,	,	_	11	punct	_	_
suggesting	VBG	B-VP	O	Other	No	No	Other	Other	###	34	suggesting	suggesting	VBG	VBG	_	11	advcl	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	35	that	that	IN	IN	_	37	mark	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	36	PTX	PTX	NN	NN	_	37	nsubj	_	_
exerts	VBZ	B-VP	O	Other	No	No	Other	Other	###	37	exerts	exerts	VBZ	VBZ	_	34	ccomp	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	38	its	its	PRP$	PRP$	_	39	nmod:poss	_	_
function	NN	I-NP	O	Other	No	No	Other	Other	###	39	function	function	NN	NN	_	37	dobj	_	_
proximal	JJ	B-ADJP	O	Other	No	No	Other	Other	###	40	proximal	proximal	JJ	JJ	_	39	amod	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	41	to	to	TO	TO	_	45	nmod	_	_
or	CC	O	O	Other	No	No	Other	Other	###	42	or	or	CC	CC	_	45	cc	_	_
at	IN	B-PP	O	Other	No	No	Other	Other	###	43	at	at	IN	IN	_	45	conj	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	44	the	the	DT	DT	_	45	det	_	_
level	NN	I-NP	O	Other	No	No	Other	Other	###	45	level	level	NN	NN	_	40	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	46	of	of	IN	IN	_	48	case	_	_
I-kappaBalpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	47	I-kappaBalpha	I-kappaBalpha	NN	NN	_	48	compound	_	_
phosphorylation	NN	I-NP	O	Other	No	No	Other	B-Phosphorylation	###	48	phosphorylation	phosphorylation	NN	NN	_	45	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	49	.	.	.	.	_	8	punct	_	_

Previous	JJ	B-NP	O	Other	No	No	Other	Other	###	1	Previous	Previous	JJ	JJ	_	2	amod	_	_
studies	NNS	I-NP	O	Other	No	No	Other	Other	###	2	studies	studies	NNS	NNS	_	18	nsubj	_	_
that	WDT	B-NP	O	Other	No	No	Other	Other	###	3	that	that	WDT	WDT	_	5	nsubj	_	_
have	VBP	B-VP	O	Other	No	No	Other	Other	###	4	have	have	VBP	VBP	_	5	aux	_	_
evaluated	VBN	I-VP	O	Other	No	No	Other	Other	###	5	evaluated	evaluated	VBN	VBN	_	2	acl:relcl	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	6	the	the	DT	DT	_	7	det	_	_
effects	NNS	I-NP	O	Other	No	Yes	Other	B-Regulation	###	7	effects	effects	NNS	NNS	_	5	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	8	of	of	IN	IN	_	12	case	_	_
cAMP	JJ	B-NP	O	Other	No	No	Other	Other	###	9	cAMP	cAMP	JJ	JJ	_	12	compound	_	_
-	-	O	O	Other	No	No	Other	Other	###	10	-	-	-	-	_	12	punct	_	_
elevating	JJ	B-NP	O	Other	No	No	Other	Other	###	11	elevating	elevating	JJ	JJ	_	12	amod	_	_
drugs	NNS	I-NP	O	Other	No	No	Other	Other	###	12	drugs	drugs	NNS	NNS	_	7	nmod	_	_
on	IN	B-PP	O	Other	No	No	Other	Other	###	13	on	on	IN	IN	_	14	case	_	_
I-kappaBalpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	14	I-kappaBalpha	I-kappaBalpha	NN	NN	_	7	nmod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	15	and	and	CC	CC	_	14	cc	_	_
NF-kappaB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	16	NF-kappaB	NF-kappaB	NN	NN	_	14	conj	_	_
have	VBP	B-VP	O	Other	No	No	Other	Other	###	17	have	have	VBP	VBP	_	18	aux	_	_
reported	VBN	I-VP	O	Other	No	No	Other	Other	###	18	reported	reported	VBN	VBN	_	0	root	_	_
conflicting	VBG	I-VP	O	Other	No	No	Other	Other	###	19	conflicting	conflicting	VBG	VBG	_	20	amod	_	_
results	NNS	B-NP	O	Other	No	No	Other	Other	###	20	results	results	NNS	NNS	_	18	dobj	_	_
.	.	O	O	Other	No	No	Other	Other	###	21	.	.	.	.	_	18	punct	_	_

Haddad	NNP	B-NP	O	Other	No	No	Other	Other	###	1	Haddad	Haddad	NNP	NNP	_	31	nsubj	_	_
et	FW	I-NP	O	Other	No	No	Other	Other	###	2	et	et	FW	FW	_	1	compound	_	_
al	FW	I-NP	O	Other	No	No	Other	Other	###	3	al	al	FW	FW	_	1	dep	_	_
.	.	O	O	Other	No	No	Other	Other	###	4	.	.	.	.	_	1	punct	_	_
reported	VBN	B-NP	O	Other	No	No	Other	Other	###	5	reported	reported	VBN	VBN	_	6	amod	_	_
results	NNS	I-NP	O	Other	No	No	Other	Other	###	6	results	results	NNS	NNS	_	1	appos	_	_
similar	JJ	B-ADJP	O	Other	No	No	Other	Other	###	7	similar	similar	JJ	JJ	_	6	amod	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	8	to	to	TO	TO	_	9	case	_	_
ours	NNS	B-NP	O	Other	No	No	Other	Other	###	9	ours	ours	NNS	NNS	_	7	nmod	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	10	with	with	IN	IN	_	14	case	_	_
respect	NN	B-NP	O	Other	No	No	Other	Other	###	11	respect	respect	NN	NN	_	14	dep	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	12	to	to	TO	TO	_	14	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	13	the	the	DT	DT	_	14	det	_	_
effects	NNS	I-NP	O	Other	No	Yes	Other	B-Regulation	###	14	effects	effects	NNS	NNS	_	7	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	15	of	of	IN	IN	_	16	case	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	16	PTX	PTX	NN	NN	_	14	nmod	_	_
on	IN	B-PP	O	Other	No	No	Other	Other	###	17	on	on	IN	IN	_	18	case	_	_
I-kappaBalpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	18	I-kappaBalpha	I-kappaBalpha	NN	NN	_	14	nmod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	19	and	and	CC	CC	_	18	cc	_	_
NF-kappaB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	20	NF-kappaB	NF-kappaB	NN	NN	_	18	conj	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	21	in	in	IN	IN	_	24	case	_	_
pulmonary	JJ	B-NP	O	Other	No	No	Other	Other	###	22	pulmonary	pulmonary	JJ	JJ	_	24	amod	_	_
epithelial	JJ	I-NP	O	Other	No	No	Other	Other	###	23	epithelial	epithelial	JJ	JJ	_	24	amod	_	_
cells.31	NN	I-NP	O	Other	No	No	Other	Other	###	24	cells.31	cells.31	NN	NN	_	18	nmod	_	_
Conversely	RB	B-ADVP	O	Other	No	No	Other	Other	###	25	Conversely	Conversely	RB	RB	_	24	advmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	26	,	,	,	,	_	24	punct	_	_
Neumann	NNP	B-NP	O	Other	No	No	Other	Other	###	27	Neumann	Neumann	NNP	NNP	_	1	appos	_	_
et	FW	I-NP	O	Other	No	No	Other	Other	###	28	et	et	FW	FW	_	27	compound	_	_
al	FW	I-NP	O	Other	No	No	Other	Other	###	29	al	al	FW	FW	_	27	dep	_	_
.	.	O	O	Other	No	No	Other	Other	###	30	.	.	.	.	_	1	punct	_	_
proposed	VBD	B-VP	O	Other	No	No	Other	Other	###	31	proposed	proposed	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	32	that	that	IN	IN	_	36	mark	_	_
increased	VBN	B-NP	O	Other	No	Yes	Other	Other	###	33	increased	increased	VBN	VBN	_	35	amod	_	_
intracellular	JJ	I-NP	O	Other	No	No	Other	Other	###	34	intracellular	intracellular	JJ	JJ	_	35	amod	_	_
cAMP	NN	I-NP	O	Other	No	No	Other	Other	###	35	cAMP	cAMP	NN	NN	_	36	nsubj	_	_
stabilizes	VBZ	B-VP	O	Other	No	No	Other	B-Regulation	###	36	stabilizes	stabilizes	VBZ	VBZ	_	31	ccomp	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	37	the	the	DT	DT	_	38	det	_	_
interaction	NN	I-NP	O	Other	No	No	Other	B-Binding	###	38	interaction	interaction	NN	NN	_	36	dobj	_	_
between	IN	B-PP	O	Other	No	No	Other	Other	###	39	between	between	IN	IN	_	40	case	_	_
I-kappaBalpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	40	I-kappaBalpha	I-kappaBalpha	NN	NN	_	38	nmod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	41	and	and	CC	CC	_	40	cc	_	_
NF-kappaB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	42	NF-kappaB	NF-kappaB	NN	NN	_	40	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	43	,	,	,	,	_	36	punct	_	_
therefore	RB	B-ADVP	O	Other	No	No	Other	Other	###	44	therefore	therefore	RB	RB	_	45	advmod	_	_
reducing	VBG	B-VP	O	Other	No	No	Other	Other	###	45	reducing	reducing	VBG	VBG	_	36	advcl	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	46	NF-kappaB	NF-kappaB	NN	NN	_	47	compound	_	_
activation.32	NN	I-NP	O	Other	No	No	Other	Other	###	47	activation.32	activation.32	NN	NN	_	45	dobj	_	_
In	IN	B-PP	O	Other	No	No	Other	Other	###	48	In	In	IN	IN	_	49	case	_	_
contrast	NN	B-NP	O	Other	No	No	Other	Other	###	49	contrast	contrast	NN	NN	_	45	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	50	,	,	,	,	_	55	punct	_	_
Takahashi	NNP	B-NP	O	Other	No	No	Other	Other	###	51	Takahashi	Takahashi	NNP	NNP	_	45	nmod	_	_
et	FW	I-NP	O	Other	No	No	Other	Other	###	52	et	et	FW	FW	_	51	compound	_	_
al	FW	I-NP	O	Other	No	No	Other	Other	###	53	al	al	FW	FW	_	51	dep	_	_
.	.	O	O	Other	No	No	Other	Other	###	54	.	.	.	.	_	51	punct	_	_
showed	VBD	B-VP	O	Other	No	No	Other	Other	###	55	showed	showed	VBD	VBD	_	36	conj	_	_
no	DT	B-NP	O	Other	No	No	Other	Other	###	56	no	no	DT	DT	_	57	neg	_	_
difference	NN	I-NP	O	Other	No	No	Other	Other	###	57	difference	difference	NN	NN	_	55	dobj	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	58	in	in	IN	IN	_	60	case	_	_
I-kappaBalpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	59	I-kappaBalpha	I-kappaBalpha	NN	NN	_	60	compound	_	_
degradation	NN	I-NP	O	Other	No	Yes	Other	B-Protein_catabolism	###	60	degradation	degradation	NN	NN	_	57	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	61	in	in	IN	IN	_	63	case	_	_
Jurkat	NN	B-NP	B-cell_line	Other	No	No	Other	Other	###	62	Jurkat	Jurkat	NN	NN	_	63	compound	_	_
T-lymphocytes	NNS	I-NP	I-cell_line	Other	No	No	Other	Other	###	63	T-lymphocytes	T-lymphocytes	NNS	NNS	_	60	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	64	in	in	IN	IN	_	66	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	65	the	the	DT	DT	_	66	det	_	_
presence	NN	I-NP	O	Other	No	No	Other	B-Regulation	###	66	presence	presence	NN	NN	_	55	nmod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	67	and	and	CC	CC	_	66	cc	_	_
absence	NN	I-NP	O	Other	No	No	Other	B-Regulation	###	68	absence	absence	NN	NN	_	66	conj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	69	of	of	IN	IN	_	70	case	_	_
forskolin	NN	B-NP	O	Other	No	No	Other	Other	###	70	forskolin	forskolin	NN	NN	_	66	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	71	,	,	,	,	_	70	punct	_	_
an	DT	B-NP	O	Other	No	No	Other	Other	###	72	an	an	DT	DT	_	76	det	_	_
alternative	JJ	I-NP	O	Other	No	No	Other	Other	###	73	alternative	alternative	JJ	JJ	_	76	amod	_	_
cAMP	NN	I-NP	O	Other	No	No	Other	Other	###	74	cAMP	cAMP	NN	NN	_	76	compound	_	_
inducing	VBG	B-VP	O	Other	No	No	Other	Other	###	75	inducing	inducing	VBG	VBG	_	76	amod	_	_
compound	NN	B-NP	O	Other	No	No	Other	Other	###	76	compound	compound	NN	NN	_	70	appos	_	_
.	.	O	O	Other	No	No	Other	Other	###	77	.	.	.	.	_	31	punct	_	_

This	DT	B-NP	O	Other	No	No	Other	Other	###	1	This	This	DT	DT	_	2	det	_	_
group	NN	I-NP	O	Other	No	No	Other	Other	###	2	group	group	NN	NN	_	4	nsubj	_	_
also	RB	B-ADVP	O	Other	No	No	Other	Other	###	3	also	also	RB	RB	_	4	advmod	_	_
demonstrated	VBD	B-VP	O	Other	No	No	Other	Other	###	4	demonstrated	demonstrated	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	5	that	that	IN	IN	_	9	mark	_	_
forskolin	NN	B-NP	O	Other	No	No	Other	Other	###	6	forskolin	forskolin	NN	NN	_	9	nsubj	_	_
did	VBD	B-VP	O	Other	No	No	Other	Other	###	7	did	did	VBD	VBD	_	9	aux	_	_
not	RB	I-VP	O	Other	No	No	Other	Other	###	8	not	not	RB	RB	_	9	neg	_	_
inhibit	VB	I-VP	O	Other	No	No	Other	Other	###	9	inhibit	inhibit	VB	VB	_	4	ccomp	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	10	the	the	DT	DT	_	14	det	_	_
DNA	JJ	I-NP	O	Other	No	No	Other	Other	###	11	DNA	DNA	JJ	JJ	_	14	compound	_	_
-	-	O	O	Other	No	No	Other	Other	###	12	-	-	-	-	_	14	punct	_	_
binding	JJ	I-NP	O	Other	No	No	Other	Other	###	13	binding	binding	JJ	JJ	_	14	compound	_	_
activity	NN	I-NP	O	Other	No	No	Other	Other	###	14	activity	activity	NN	NN	_	9	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	15	of	of	IN	IN	_	16	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	16	NF-kappaB	NF-kappaB	NN	NN	_	14	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	17	and	and	CC	CC	_	9	cc	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	18	that	that	IN	IN	_	22	mark	_	_
CREB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	19	CREB	CREB	NN	NN	_	22	nsubjpass	_	_
was	VBD	B-VP	O	Other	No	No	Other	Other	###	20	was	was	VBD	VBD	_	22	auxpass	_	_
not	RB	I-VP	O	Other	No	No	Other	Other	###	21	not	not	RB	RB	_	22	neg	_	_
involved	VBN	I-VP	O	Other	No	Yes	Other	Other	###	22	involved	involved	VBN	VBN	_	9	conj	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	23	in	in	IN	IN	_	27	case	_	_
forskolin	JJ	B-NP	O	Other	No	No	Other	Other	###	24	forskolin	forskolin	JJ	JJ	_	27	amod	_	_
-	-	O	O	Other	No	No	Other	Other	###	25	-	-	-	-	_	26	punct	_	_
induced	JJ	B-NP	O	Other	No	Yes	Other	Other	###	26	induced	induced	JJ	JJ	_	27	amod	_	_
decrease	NN	I-NP	O	Other	No	Yes	Other	Other	###	27	decrease	decrease	NN	NN	_	22	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	28	in	in	IN	IN	_	33	case	_	_
p65	NN	B-NP	B-protein	B-Protein	Yes	No	Other	Other	###	29	p65	p65	NN	NN	_	33	compound	_	_
transcriptional	JJ	I-NP	O	Other	No	No	Other	Other	###	30	transcriptional	transcriptional	JJ	JJ	_	33	amod	_	_
activity.33	NN	I-NP	O	Other	No	No	Other	Other	###	31	activity.33	activity.33	NN	NN	_	33	compound	_	_
Similar	JJ	I-NP	O	Other	No	No	Other	Other	###	32	Similar	Similar	JJ	JJ	_	33	amod	_	_
results	NNS	I-NP	O	Other	No	No	Other	Other	###	33	results	results	NNS	NNS	_	27	nmod	_	_
were	VBD	B-VP	O	Other	No	No	Other	Other	###	34	were	were	VBD	VBD	_	35	auxpass	_	_
reported	VBN	I-VP	O	Other	No	No	Other	Other	###	35	reported	reported	VBN	VBN	_	9	conj	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	36	by	by	IN	IN	_	37	case	_	_
Ollivier	NNP	B-NP	O	Other	No	No	Other	Other	###	37	Ollivier	Ollivier	NNP	NNP	_	35	nmod	_	_
et	FW	I-NP	O	Other	No	No	Other	Other	###	38	et	et	FW	FW	_	39	compound	_	_
al	FW	I-NP	O	Other	No	No	Other	Other	###	39	al	al	FW	FW	_	37	dep	_	_
.	.	O	O	Other	No	No	Other	Other	###	40	.	.	.	.	_	35	punct	_	_
using	VBG	B-VP	O	Other	No	No	Other	Other	###	41	using	using	VBG	VBG	_	35	xcomp	_	_
THP-1	NN	B-NP	B-cell_line	Other	No	No	Other	Other	###	42	THP-1	THP-1	NN	NN	_	43	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	No	No	Other	Other	###	43	cells	cells	NNS	NNS	_	41	dobj	_	_
and	CC	O	O	Other	No	No	Other	Other	###	44	and	and	CC	CC	_	43	cc	_	_
endothelial	JJ	B-NP	B-cell_type	Other	No	No	Other	Other	###	45	endothelial	endothelial	JJ	JJ	_	46	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	No	No	Other	Other	###	46	cells	cells	NNS	NNS	_	43	conj	_	_
treated	VBN	B-VP	O	Other	No	No	Other	Other	###	47	treated	treated	VBN	VBN	_	43	acl	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	48	with	with	IN	IN	_	49	case	_	_
forskolin	NN	B-NP	O	Other	No	No	Other	Other	###	49	forskolin	forskolin	NN	NN	_	47	nmod	_	_
or	CC	I-NP	O	Other	No	No	Other	Other	###	50	or	or	CC	CC	_	49	cc	_	_
dibutyryl	NN	I-NP	O	Other	No	No	Other	Other	###	51	dibutyryl	dibutyryl	NN	NN	_	52	compound	_	_
cAMP	NN	I-NP	O	Other	No	No	Other	Other	###	52	cAMP	cAMP	NN	NN	_	49	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	53	,	,	,	,	_	43	punct	_	_
two	CD	B-NP	O	Other	No	No	Other	Other	###	54	two	two	CD	CD	_	55	nummod	_	_
agents	NNS	I-NP	O	Other	No	No	Other	Other	###	55	agents	agents	NNS	NNS	_	43	appos	_	_
known	VBN	B-VP	O	Other	No	No	Other	Other	###	56	known	known	VBN	VBN	_	55	acl	_	_
to	TO	B-VP	O	Other	No	No	Other	Other	###	57	to	to	TO	TO	_	58	mark	_	_
function	VB	I-VP	O	Other	No	No	Other	Other	###	58	function	function	VB	VB	_	56	xcomp	_	_
through	IN	B-PP	O	Other	No	No	Other	Other	###	59	through	through	IN	IN	_	61	case	_	_
cAMP	NN	B-NP	O	Other	No	No	Other	Other	###	60	cAMP	cAMP	NN	NN	_	61	compound	_	_
elevation	NN	I-NP	O	Other	No	No	Other	Other	###	61	elevation	elevation	NN	NN	_	58	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	62	and	and	CC	CC	_	61	cc	_	_
subsequent	JJ	B-NP	O	Other	No	No	Other	Other	###	63	subsequent	subsequent	JJ	JJ	_	65	amod	_	_
PKA	NN	I-NP	B-protein	Other	No	No	Other	Other	###	64	PKA	PKA	NN	NN	_	65	compound	_	_
activation.9	NN	I-NP	O	Other	No	No	Other	Other	###	65	activation.9	activation.9	NN	NN	_	49	conj	_	_
The	DT	B-NP	O	Other	No	No	Other	Other	###	66	The	The	DT	DT	_	67	det	_	_
differences	NNS	I-NP	O	Other	No	No	Other	Other	###	67	differences	differences	NNS	NNS	_	77	nsubjpass	_	_
between	IN	B-PP	O	Other	No	No	Other	Other	###	68	between	between	IN	IN	_	70	case	_	_
our	PRP$	B-NP	O	Other	No	No	Other	Other	###	69	our	our	PRP$	PRP$	_	70	nmod:poss	_	_
results	NNS	I-NP	O	Other	No	No	Other	Other	###	70	results	results	NNS	NNS	_	67	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	71	and	and	CC	CC	_	70	cc	_	_
those	DT	B-NP	O	Other	No	No	Other	Other	###	72	those	those	DT	DT	_	70	conj	_	_
mentioned	VBN	B-VP	O	Other	No	No	Other	Other	###	73	mentioned	mentioned	VBN	VBN	_	72	acl	_	_
above	IN	B-PP	O	Other	No	No	Other	Other	###	74	above	above	IN	IN	_	73	advmod	_	_
may	MD	B-VP	O	Other	No	No	Other	Other	###	75	may	may	MD	MD	_	77	aux	_	_
be	VB	I-VP	O	Other	No	No	Other	Other	###	76	be	be	VB	VB	_	77	auxpass	_	_
explained	VBN	I-VP	O	Other	No	No	Other	Other	###	77	explained	explained	VBN	VBN	_	41	advcl	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	78	by	by	IN	IN	_	80	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	79	the	the	DT	DT	_	80	det	_	_
use	NN	I-NP	O	Other	No	No	Other	Other	###	80	use	use	NN	NN	_	77	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	81	of	of	IN	IN	_	84	case	_	_
different	JJ	B-NP	O	Other	No	No	Other	Other	###	82	different	different	JJ	JJ	_	84	amod	_	_
cell	NN	I-NP	O	Other	No	No	Other	Other	###	83	cell	cell	NN	NN	_	84	compound	_	_
types	NNS	I-NP	O	Other	No	No	Other	Other	###	84	types	types	NNS	NNS	_	80	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	85	and	and	CC	CC	_	84	cc	_	_
exogenous	JJ	B-NP	O	Other	No	No	Other	Other	###	86	exogenous	exogenous	JJ	JJ	_	87	amod	_	_
stimulants	NNS	I-NP	O	Other	No	No	Other	Other	###	87	stimulants	stimulants	NNS	NNS	_	84	conj	_	_
.	.	O	O	Other	No	No	Other	Other	###	88	.	.	.	.	_	4	punct	_	_

It	PRP	B-NP	O	Other	No	No	Other	Other	###	1	It	It	PRP	PRP	_	4	nsubj	_	_
is	VBZ	B-VP	O	Other	No	No	Other	Other	###	2	is	is	VBZ	VBZ	_	4	cop	_	_
also	RB	B-ADVP	O	Other	No	No	Other	Other	###	3	also	also	RB	RB	_	4	advmod	_	_
possible	JJ	B-ADJP	O	Other	No	No	Other	Other	###	4	possible	possible	JJ	JJ	_	0	root	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	5	that	that	IN	IN	_	7	mark	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	6	PTX	PTX	NN	NN	_	7	nsubj	_	_
exerts	VBZ	B-VP	O	Other	No	No	Other	Other	###	7	exerts	exerts	VBZ	VBZ	_	4	ccomp	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	8	its	its	PRP$	PRP$	_	10	nmod:poss	_	_
anti-inflammatory	JJ	I-NP	O	Other	No	No	Other	Other	###	9	anti-inflammatory	anti-inflammatory	JJ	JJ	_	10	amod	_	_
effects	NNS	I-NP	O	Other	No	Yes	Other	Other	###	10	effects	effects	NNS	NNS	_	7	dobj	_	_
on	IN	B-PP	O	Other	No	No	Other	Other	###	11	on	on	IN	IN	_	14	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	12	the	the	DT	DT	_	14	det	_	_
NF-kappaB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	13	NF-kappaB	NF-kappaB	NN	NN	_	14	compound	_	_
pathway	NN	I-NP	O	Other	No	No	Other	Other	###	14	pathway	pathway	NN	NN	_	7	nmod	_	_
independent	JJ	B-ADJP	O	Other	No	Yes	Other	Other	###	15	independent	independent	JJ	JJ	_	14	amod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	16	of	of	IN	IN	_	17	case	_	_
PKA	NN	B-NP	B-protein	Other	No	No	Other	Other	###	17	PKA	PKA	NN	NN	_	15	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	18	,	,	,	,	_	7	punct	_	_
as	IN	B-SBAR	O	Other	No	No	Other	Other	###	19	as	as	IN	IN	_	20	mark	_	_
suggested	VBN	B-VP	O	Other	No	No	Other	Other	###	20	suggested	suggested	VBN	VBN	_	7	advcl	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	21	by	by	IN	IN	_	24	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	22	the	the	DT	DT	_	24	det	_	_
continued	JJ	I-NP	O	Other	No	No	Other	Other	###	23	continued	continued	JJ	JJ	_	24	amod	_	_
attenuation	NN	I-NP	O	Other	No	Yes	Other	B-Negative_regulation	###	24	attenuation	attenuation	NN	NN	_	20	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	25	of	of	IN	IN	_	30	case	_	_
LPS	JJ	B-NP	O	Other	No	No	Other	Other	###	26	LPS	LPS	JJ	JJ	_	30	compound	_	_
-	-	O	O	Other	No	No	Other	Other	###	27	-	-	-	-	_	26	punct	_	_
induced	JJ	B-NP	O	Other	No	Yes	Other	B-Positive_regulation	###	28	induced	induced	JJ	JJ	_	26	dep	_	_
TNF-alpha	NN	I-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	29	TNF-alpha	TNF-alpha	NN	NN	_	30	compound	_	_
production	NN	I-NP	O	Other	No	Yes	Other	B-Gene_expression	###	30	production	production	NN	NN	_	24	nmod	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	31	by	by	IN	IN	_	32	case	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	32	PTX	PTX	NN	NN	_	30	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	33	in	in	IN	IN	_	35	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	34	the	the	DT	DT	_	35	det	_	_
presence	NN	I-NP	O	Other	No	Yes	Other	B-Regulation	###	35	presence	presence	NN	NN	_	24	nmod	_	_
or	CC	I-NP	O	Other	No	No	Other	I-Regulation	###	36	or	or	CC	CC	_	35	cc	_	_
absence	NN	I-NP	O	Other	No	Yes	Other	I-Regulation	###	37	absence	absence	NN	NN	_	35	conj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	38	of	of	IN	IN	_	40	case	_	_
PKA	NN	B-NP	B-protein	Other	No	No	Other	Other	###	39	PKA	PKA	NN	NN	_	40	compound	_	_
inhibition	NN	I-NP	O	Other	No	No	Other	Other	###	40	inhibition	inhibition	NN	NN	_	35	nmod	_	_
observed	VBN	B-VP	O	Other	No	No	Other	Other	###	41	observed	observed	VBN	VBN	_	35	acl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	42	in	in	IN	IN	_	44	case	_	_
this	DT	B-NP	O	Other	No	No	Other	Other	###	43	this	this	DT	DT	_	44	det	_	_
study	NN	I-NP	O	Other	No	No	Other	Other	###	44	study	study	NN	NN	_	41	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	45	.	.	.	.	_	4	punct	_	_

This	DT	B-NP	O	Other	No	No	Other	Other	###	1	This	This	DT	DT	_	2	det	_	_
hypothesis	NN	I-NP	O	Other	No	No	Other	Other	###	2	hypothesis	hypothesis	NN	NN	_	6	nsubj	_	_
is	VBZ	B-VP	O	Other	No	No	Other	Other	###	3	is	is	VBZ	VBZ	_	6	cop	_	_
currently	RB	B-ADVP	O	Other	No	No	Other	Other	###	4	currently	currently	RB	RB	_	6	advmod	_	_
under	IN	B-PP	O	Other	No	No	Other	Other	###	5	under	under	IN	IN	_	6	case	_	_
investigation	NN	B-NP	O	Other	No	No	Other	Other	###	6	investigation	investigation	NN	NN	_	0	root	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	7	in	in	IN	IN	_	9	case	_	_
our	PRP$	B-NP	O	Other	No	No	Other	Other	###	8	our	our	PRP$	PRP$	_	9	nmod:poss	_	_
laboratory	NN	I-NP	O	Other	No	No	Other	Other	###	9	laboratory	laboratory	NN	NN	_	6	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	10	.	.	.	.	_	6	punct	_	_

Furthermore	RB	B-ADVP	O	Other	No	No	Other	Other	###	1	Furthermore	Furthermore	RB	RB	_	4	advmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	2	,	,	,	,	_	4	punct	_	_
we	PRP	B-NP	O	Other	No	No	Other	Other	###	3	we	we	PRP	PRP	_	4	nsubj	_	_
utilized	VBD	B-VP	O	Other	No	No	Other	Other	###	4	utilized	utilized	VBD	VBD	_	0	root	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	5	a	a	DT	DT	_	8	det	_	_
broad	JJ	I-NP	O	Other	No	No	Other	Other	###	6	broad	broad	JJ	JJ	_	8	amod	_	_
PKA	NN	I-NP	B-protein	Other	No	No	Other	Other	###	7	PKA	PKA	NN	NN	_	8	compound	_	_
inhibitor	NN	I-NP	O	Other	No	No	Other	Other	###	8	inhibitor	inhibitor	NN	NN	_	4	dobj	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	9	in	in	IN	IN	_	11	case	_	_
this	DT	B-NP	O	Other	No	No	Other	Other	###	10	this	this	DT	DT	_	11	det	_	_
study	NN	I-NP	O	Other	No	No	Other	Other	###	11	study	study	NN	NN	_	4	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	12	in	in	IN	IN	_	13	case	_	_
addition	NN	B-NP	O	Other	No	No	Other	Other	###	13	addition	addition	NN	NN	_	4	nmod	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	14	to	to	TO	TO	_	15	case	_	_
H89	NN	B-NP	B-protein	Other	No	No	Other	Other	###	15	H89	H89	NN	NN	_	13	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	16	,	,	,	,	_	4	punct	_	_
but	CC	O	O	Other	No	No	Other	Other	###	17	but	but	CC	CC	_	4	cc	_	_
did	VBD	B-VP	O	Other	No	No	Other	Other	###	18	did	did	VBD	VBD	_	20	aux	_	_
not	RB	I-VP	O	Other	No	No	Other	Other	###	19	not	not	RB	RB	_	20	neg	_	_
examine	VB	I-VP	O	Other	No	No	Other	Other	###	20	examine	examine	VB	VB	_	4	conj	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	21	the	the	DT	DT	_	22	det	_	_
effect	NN	I-NP	O	Other	No	No	Other	Other	###	22	effect	effect	NN	NN	_	20	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	23	of	of	IN	IN	_	25	case	_	_
specific	JJ	B-NP	O	Other	No	No	Other	Other	###	24	specific	specific	JJ	JJ	_	25	amod	_	_
inhibition	NN	I-NP	O	Other	No	No	Other	Other	###	25	inhibition	inhibition	NN	NN	_	22	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	26	of	of	IN	IN	_	29	case	_	_
various	JJ	B-NP	O	Other	No	No	Other	Other	###	27	various	various	JJ	JJ	_	29	amod	_	_
PKA	NN	I-NP	B-protein	Other	No	No	Other	Other	###	28	PKA	PKA	NN	NN	_	29	compound	_	_
isoforms	NNS	I-NP	I-protein	Other	No	No	Other	Other	###	29	isoforms	isoforms	NNS	NNS	_	25	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	30	.	.	.	.	_	4	punct	_	_

This	DT	B-NP	O	Other	No	No	Other	Other	###	1	This	This	DT	DT	_	2	det	_	_
information	NN	I-NP	O	Other	No	No	Other	Other	###	2	information	information	NN	NN	_	4	nsubj	_	_
may	MD	B-VP	O	Other	No	No	Other	Other	###	3	may	may	MD	MD	_	4	aux	_	_
yield	VB	I-VP	O	Other	No	No	Other	Other	###	4	yield	yield	VB	VB	_	0	root	_	_
more	JJR	B-NP	O	Other	No	No	Other	Other	###	5	more	more	JJR	JJR	_	6	amod	_	_
insight	NN	I-NP	O	Other	No	No	Other	Other	###	6	insight	insight	NN	NN	_	4	dobj	_	_
into	IN	B-PP	O	Other	No	No	Other	Other	###	7	into	into	IN	IN	_	9	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	8	the	the	DT	DT	_	9	det	_	_
mechanism	NN	I-NP	O	Other	No	No	Other	Other	###	9	mechanism	mechanism	NN	NN	_	6	nmod	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	10	by	by	IN	IN	_	11	case	_	_
which	WDT	B-NP	O	Other	No	No	Other	Other	###	11	which	which	WDT	WDT	_	13	nmod	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	12	PTX	PTX	NN	NN	_	13	nsubj	_	_
exerts	VBZ	B-VP	O	Other	No	No	Other	Other	###	13	exerts	exerts	VBZ	VBZ	_	9	acl:relcl	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	14	its	its	PRP$	PRP$	_	16	nmod:poss	_	_
down-regulatory	JJ	I-NP	O	Other	No	No	Other	Other	###	15	down-regulatory	down-regulatory	JJ	JJ	_	16	amod	_	_
effects	NNS	I-NP	O	Other	No	Yes	Other	Other	###	16	effects	effects	NNS	NNS	_	13	dobj	_	_
.	.	O	O	Other	No	No	Other	Other	###	17	.	.	.	.	_	4	punct	_	_

PDE	NN	B-NP	O	Other	No	No	Other	Other	###	1	PDE	PDE	NN	NN	_	2	compound	_	_
inhibitors	NNS	I-NP	O	Other	No	No	Other	Other	###	2	inhibitors	inhibitors	NNS	NNS	_	5	nsubj	_	_
may	MD	B-VP	O	Other	No	No	Other	Other	###	3	may	may	MD	MD	_	5	aux	_	_
also	RB	I-VP	O	Other	No	No	Other	Other	###	4	also	also	RB	RB	_	5	advmod	_	_
downregulate	VB	I-VP	O	Other	No	Yes	Other	Other	###	5	downregulate	downregulate	VB	VB	_	0	root	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	6	NF-kappaB	NF-kappaB	NN	NN	_	8	compound	_	_
transcriptional	JJ	I-NP	O	Other	No	No	Other	Other	###	7	transcriptional	transcriptional	JJ	JJ	_	8	amod	_	_
activity	NN	I-NP	O	Other	No	No	Other	Other	###	8	activity	activity	NN	NN	_	5	dobj	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	9	by	by	IN	IN	_	10	mark	_	_
altering	VBG	B-VP	O	Other	No	No	Other	Other	###	10	altering	altering	VBG	VBG	_	5	advcl	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	11	the	the	DT	DT	_	13	det	_	_
competitive	JJ	I-NP	O	Other	No	No	Other	Other	###	12	competitive	competitive	JJ	JJ	_	13	amod	_	_
binding	NN	I-NP	O	Other	No	No	Other	Other	###	13	binding	binding	NN	NN	_	10	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	14	of	of	IN	IN	_	15	case	_	_
CREB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	15	CREB	CREB	NN	NN	_	13	nmod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	16	and	and	CC	CC	_	15	cc	_	_
NF-kappaB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	17	NF-kappaB	NF-kappaB	NN	NN	_	15	conj	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	18	to	to	TO	TO	_	21	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	19	the	the	DT	DT	_	21	det	_	_
promoter	NN	I-NP	B-DNA	Other	No	No	Other	Other	###	20	promoter	promoter	NN	NN	_	21	compound	_	_
regions	NNS	I-NP	I-DNA	Other	No	No	Other	Other	###	21	regions	regions	NNS	NNS	_	13	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	22	of	of	IN	IN	_	24	case	_	_
pro-inflammatory	JJ	B-NP	B-DNA	Other	No	No	Other	Other	###	23	pro-inflammatory	pro-inflammatory	JJ	JJ	_	24	amod	_	_
genes	NNS	I-NP	I-DNA	Other	No	No	Other	Other	###	24	genes	genes	NNS	NNS	_	21	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	25	.	.	.	.	_	5	punct	_	_

Herein	RB	B-ADVP	O	Other	No	No	Other	Other	###	1	Herein	Herein	RB	RB	_	4	advmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	2	,	,	,	,	_	4	punct	_	_
we	PRP	B-NP	O	Other	No	No	Other	Other	###	3	we	we	PRP	PRP	_	4	nsubj	_	_
showed	VBD	B-VP	O	Other	No	No	Other	Other	###	4	showed	showed	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	5	that	that	IN	IN	_	15	mark	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	6	the	the	DT	DT	_	7	det	_	_
activation	NN	I-NP	O	Other	No	No	Other	Other	###	7	activation	activation	NN	NN	_	15	nsubjpass	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	8	and	and	CC	CC	_	7	cc	_	_
DNA	NN	I-NP	O	Other	No	No	Other	Other	###	9	DNA	DNA	NN	NN	_	11	compound	_	_
binding	NN	I-NP	O	Other	No	No	Other	Other	###	10	binding	binding	NN	NN	_	11	compound	_	_
activity	NN	I-NP	O	Other	No	No	Other	Other	###	11	activity	activity	NN	NN	_	7	conj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	12	of	of	IN	IN	_	13	case	_	_
CREB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	13	CREB	CREB	NN	NN	_	7	nmod	_	_
is	VBZ	B-VP	O	Other	No	No	Other	Other	###	14	is	is	VBZ	VBZ	_	15	auxpass	_	_
upregulated	VBN	I-VP	O	Other	No	No	Other	Other	###	15	upregulated	upregulated	VBN	VBN	_	4	ccomp	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	16	in	in	IN	IN	_	21	case	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	17	a	a	DT	DT	_	21	det	_	_
dose	JJ	I-NP	O	Other	No	No	Other	Other	###	18	dose	dose	JJ	JJ	_	21	amod	_	_
-	-	O	O	Other	No	No	Other	Other	###	19	-	-	-	-	_	21	punct	_	_
dependent	JJ	I-NP	O	Other	No	No	Other	Other	###	20	dependent	dependent	JJ	JJ	_	21	amod	_	_
manner	NN	I-NP	O	Other	No	No	Other	Other	###	21	manner	manner	NN	NN	_	15	nmod	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	22	by	by	IN	IN	_	23	case	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	23	PTX	PTX	NN	NN	_	15	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	24	.	.	.	.	_	4	punct	_	_

Of	IN	B-PP	O	Other	No	No	Other	Other	###	1	Of	Of	IN	IN	_	2	case	_	_
note	NN	B-NP	O	Other	No	No	Other	Other	###	2	note	note	NN	NN	_	11	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	3	,	,	,	,	_	11	punct	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	4	the	the	DT	DT	_	5	det	_	_
increase	NN	I-NP	O	Other	No	Yes	Other	Other	###	5	increase	increase	NN	NN	_	11	nsubjpass	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	6	in	in	IN	IN	_	8	case	_	_
CREB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	7	CREB	CREB	NN	NN	_	8	compound	_	_
activity	NN	I-NP	O	Other	No	No	Other	Other	###	8	activity	activity	NN	NN	_	5	nmod	_	_
was	VBD	B-VP	O	Other	No	No	Other	Other	###	9	was	was	VBD	VBD	_	11	auxpass	_	_
slightly	RB	I-VP	O	Other	No	No	Other	Other	###	10	slightly	slightly	RB	RB	_	11	advmod	_	_
alleviated	VBN	I-VP	O	Other	No	No	Other	Other	###	11	alleviated	alleviated	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	12	by	by	IN	IN	_	14	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	13	the	the	DT	DT	_	14	det	_	_
addition	NN	I-NP	O	Other	No	No	Other	Other	###	14	addition	addition	NN	NN	_	11	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	15	of	of	IN	IN	_	16	case	_	_
LPS	NN	B-NP	O	Other	No	No	Other	Other	###	16	LPS	LPS	NN	NN	_	14	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	17	,	,	,	,	_	11	punct	_	_
suggesting	VBG	B-VP	O	Other	No	No	Other	Other	###	18	suggesting	suggesting	VBG	VBG	_	11	advcl	_	_
competition	NN	B-NP	O	Other	No	No	Other	Other	###	19	competition	competition	NN	NN	_	18	dobj	_	_
between	IN	B-PP	O	Other	No	No	Other	Other	###	20	between	between	IN	IN	_	28	case	_	_
PTX	JJ	B-NP	B-DNA	Other	No	No	Other	Other	###	21	PTX	PTX	JJ	JJ	_	28	amod	_	_
-	-	O	O	Other	No	No	Other	Other	###	22	-	-	-	-	_	21	punct	_	_
induced	JJ	B-NP	B-DNA	Other	No	Yes	Other	Other	###	23	induced	induced	JJ	JJ	_	21	dep	_	_
CREB	JJ	I-NP	I-DNA	Other	No	No	Other	Other	###	24	CREB	CREB	JJ	JJ	_	28	amod	_	_
-	-	O	O	Other	No	No	Other	Other	###	25	-	-	-	-	_	28	punct	_	_
associated	JJ	I-NP	I-DNA	Other	No	No	Other	Other	###	26	associated	associated	JJ	JJ	_	24	dep	_	_
gene	NN	I-NP	I-DNA	Other	No	No	Other	Other	###	27	gene	gene	NN	NN	_	28	compound	_	_
transcription	NN	I-NP	O	Other	No	No	Other	Other	###	28	transcription	transcription	NN	NN	_	19	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	29	and	and	CC	CC	_	28	cc	_	_
those	DT	B-NP	O	Other	No	No	Other	Other	###	30	those	those	DT	DT	_	31	det	_	_
factors	NNS	I-NP	O	Other	No	No	Other	Other	###	31	factors	factors	NNS	NNS	_	28	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	32	,	,	,	,	_	31	punct	_	_
such	JJ	B-PP	O	Other	No	No	Other	Other	###	33	such	such	JJ	JJ	_	35	case	_	_
as	IN	I-PP	O	Other	No	No	Other	Other	###	34	as	as	IN	IN	_	33	mwe	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	35	NF-kappaB	NF-kappaB	NN	NN	_	31	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	36	,	,	,	,	_	31	punct	_	_
which	WDT	B-NP	O	Other	No	No	Other	Other	###	37	which	which	WDT	WDT	_	40	nsubjpass	_	_
may	MD	B-VP	O	Other	No	No	Other	Other	###	38	may	may	MD	MD	_	40	aux	_	_
be	VB	I-VP	O	Other	No	No	Other	Other	###	39	be	be	VB	VB	_	40	auxpass	_	_
upregulated	VBN	I-VP	O	Other	No	No	Other	Other	###	40	upregulated	upregulated	VBN	VBN	_	31	acl:relcl	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	41	by	by	IN	IN	_	43	case	_	_
LPS	NN	B-NP	O	Other	No	No	Other	Other	###	42	LPS	LPS	NN	NN	_	43	compound	_	_
exposure	NN	I-NP	O	Other	No	No	Other	Other	###	43	exposure	exposure	NN	NN	_	40	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	44	.	.	.	.	_	11	punct	_	_

This	DT	B-NP	O	Other	No	No	Other	Other	###	1	This	This	DT	DT	_	2	det	_	_
competition	NN	I-NP	O	Other	No	No	Other	Other	###	2	competition	competition	NN	NN	_	5	nsubjpass	_	_
has	VBZ	B-VP	O	Other	No	No	Other	Other	###	3	has	has	VBZ	VBZ	_	5	aux	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	4	been	been	VBN	VBN	_	5	auxpass	_	_
postulated	VBN	I-VP	O	Other	No	No	Other	Other	###	5	postulated	postulated	VBN	VBN	_	0	root	_	_
to	TO	I-VP	O	Other	No	No	Other	Other	###	6	to	to	TO	TO	_	7	mark	_	_
involve	VB	I-VP	O	Other	No	No	Other	Other	###	7	involve	involve	VB	VB	_	5	xcomp	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	8	the	the	DT	DT	_	9	det	_	_
recruitment	NN	I-NP	O	Other	No	No	Other	Other	###	9	recruitment	recruitment	NN	NN	_	7	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	10	of	of	IN	IN	_	12	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	11	the	the	DT	DT	_	12	det	_	_
co-activator	NN	I-NP	B-protein	Other	No	No	Other	Other	###	12	co-activator	co-activator	NN	NN	_	9	nmod	_	_
CBP	NN	I-NP	B-protein	B-Protein	No	No	Other	Other	###	13	CBP	CBP	NN	NN	_	12	dep	_	_
and	CC	O	O	Other	No	No	Other	Other	###	14	and	and	CC	CC	_	12	cc	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	15	its	its	PRP$	PRP$	_	16	nmod:poss	_	_
homologue	NN	I-NP	O	Other	No	No	Other	Other	###	16	homologue	homologue	NN	NN	_	13	conj	_	_
p300	NN	B-NP	B-protein	B-Protein	No	No	Other	Other	###	17	p300	p300	NN	NN	_	16	dep	_	_
34	NN	B-NP	O	Other	No	No	Other	Other	###	18	34	34	NN	NN	_	17	nummod	_	_
,	,	O	O	Other	No	No	Other	Other	###	19	,	,	,	,	_	7	punct	_	_
suggesting	VBG	B-VP	O	Other	No	No	Other	Other	###	20	suggesting	suggesting	VBG	VBG	_	7	advcl	_	_
an	DT	B-NP	O	Other	No	No	Other	Other	###	21	an	an	DT	DT	_	23	det	_	_
alternative	JJ	I-NP	O	Other	No	No	Other	Other	###	22	alternative	alternative	JJ	JJ	_	23	amod	_	_
mechanism	NN	I-NP	O	Other	No	No	Other	Other	###	23	mechanism	mechanism	NN	NN	_	20	dobj	_	_
that	WDT	B-NP	O	Other	No	No	Other	Other	###	24	that	that	WDT	WDT	_	27	nsubjpass	_	_
may	MD	B-VP	O	Other	No	No	Other	Other	###	25	may	may	MD	MD	_	27	aux	_	_
be	VB	I-VP	O	Other	No	No	Other	Other	###	26	be	be	VB	VB	_	27	auxpass	_	_
involved	VBN	I-VP	O	Other	No	Yes	Other	Other	###	27	involved	involved	VBN	VBN	_	23	acl:relcl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	28	in	in	IN	IN	_	31	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	29	the	the	DT	DT	_	31	det	_	_
anti-inflammatory	JJ	I-NP	O	Other	No	No	Other	Other	###	30	anti-inflammatory	anti-inflammatory	JJ	JJ	_	31	amod	_	_
actions	NNS	I-NP	O	Other	No	No	Other	Other	###	31	actions	actions	NNS	NNS	_	27	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	32	of	of	IN	IN	_	33	case	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	33	PTX	PTX	NN	NN	_	31	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	34	.	.	.	.	_	5	punct	_	_

Future	JJ	B-NP	O	Other	No	No	Other	Other	###	1	Future	Future	JJ	JJ	_	2	amod	_	_
studies	NNS	I-NP	O	Other	No	No	Other	Other	###	2	studies	studies	NNS	NNS	_	4	nsubjpass	_	_
are	VBP	B-VP	O	Other	No	No	Other	Other	###	3	are	are	VBP	VBP	_	4	auxpass	_	_
planned	VBN	I-VP	O	Other	No	No	Other	Other	###	4	planned	planned	VBN	VBN	_	0	root	_	_
to	TO	I-VP	O	Other	No	No	Other	Other	###	5	to	to	TO	TO	_	6	mark	_	_
delineate	VB	I-VP	O	Other	No	No	Other	Other	###	6	delineate	delineate	VB	VB	_	4	xcomp	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	7	the	the	DT	DT	_	8	det	_	_
validity	NN	I-NP	O	Other	No	No	Other	Other	###	8	validity	validity	NN	NN	_	6	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	9	of	of	IN	IN	_	12	case	_	_
this	DT	B-NP	O	Other	No	No	Other	Other	###	10	this	this	DT	DT	_	12	det	_	_
potential	JJ	I-NP	O	Other	No	No	Other	Other	###	11	potential	potential	JJ	JJ	_	12	amod	_	_
mechanism	NN	I-NP	O	Other	No	No	Other	Other	###	12	mechanism	mechanism	NN	NN	_	8	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	13	.	.	.	.	_	4	punct	_	_

The	DT	B-NP	O	Other	No	No	Other	Other	###	1	The	The	DT	DT	_	2	det	_	_
effects	NNS	I-NP	O	Other	No	Yes	Other	Other	###	2	effects	effects	NNS	NNS	_	22	nsubjpass	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	3	of	of	IN	IN	_	4	case	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	4	PTX	PTX	NN	NN	_	2	nmod	_	_
on	IN	B-PP	O	Other	No	No	Other	Other	###	5	on	on	IN	IN	_	8	case	_	_
other	JJ	B-NP	O	Other	No	No	Other	Other	###	6	other	other	JJ	JJ	_	8	amod	_	_
transcription	NN	I-NP	B-protein	Other	No	No	Other	Other	###	7	transcription	transcription	NN	NN	_	8	compound	_	_
factors	NNS	I-NP	I-protein	Other	No	No	Other	Other	###	8	factors	factors	NNS	NNS	_	2	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	9	,	,	,	,	_	8	punct	_	_
such	JJ	B-PP	O	Other	No	No	Other	Other	###	10	such	such	JJ	JJ	_	12	case	_	_
as	IN	I-PP	O	Other	No	No	Other	Other	###	11	as	as	IN	IN	_	10	mwe	_	_
AP-1	NN	B-NP	B-protein	Other	No	No	Other	Other	###	12	AP-1	AP-1	NN	NN	_	8	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	13	,	,	,	,	_	12	punct	_	_
c-fos	NN	B-NP	B-DNA	B-Protein	No	No	Other	Other	###	14	c-fos	c-fos	NN	NN	_	12	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	15	,	,	,	,	_	12	punct	_	_
and	CC	O	O	Other	No	No	Other	Other	###	16	and	and	CC	CC	_	12	cc	_	_
c-jun	NN	B-NP	B-DNA	B-Protein	No	No	Other	Other	###	17	c-jun	c-jun	NN	NN	_	12	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	18	,	,	,	,	_	8	punct	_	_
can	MD	B-VP	O	Other	No	No	Other	Other	###	19	can	can	MD	MD	_	22	aux	_	_
not	RB	I-VP	O	Other	No	No	Other	Other	###	20	not	not	RB	RB	_	22	neg	_	_
be	VB	I-VP	O	Other	No	No	Other	Other	###	21	be	be	VB	VB	_	22	auxpass	_	_
ruled	VBN	I-VP	O	Other	No	No	Other	Other	###	22	ruled	ruled	VBN	VBN	_	0	root	_	_
out	RP	B-PRT	O	Other	No	No	Other	Other	###	23	out	out	RP	RP	_	22	compound:prt	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	24	by	by	IN	IN	_	26	case	_	_
our	PRP$	B-NP	O	Other	No	No	Other	Other	###	25	our	our	PRP$	PRP$	_	26	nmod:poss	_	_
experiments	NNS	I-NP	O	Other	No	No	Other	Other	###	26	experiments	experiments	NNS	NNS	_	22	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	27	.	.	.	.	_	22	punct	_	_

Activation	NN	B-NP	O	Other	No	No	Other	B-Positive_regulation	###	1	Activation	Activation	NN	NN	_	21	nsubjpass	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	2	of	of	IN	IN	_	3	case	_	_
AP-1	NN	B-NP	B-protein	Other	No	No	Other	Other	###	3	AP-1	AP-1	NN	NN	_	1	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	4	and	and	CC	CC	_	3	cc	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	5	its	its	PRP$	PRP$	_	6	nmod:poss	_	_
components	NNS	I-NP	O	Other	No	No	Other	Other	###	6	components	components	NNS	NNS	_	3	conj	_	_
(	(	O	O	Other	No	No	Other	Other	###	7	(	(	(	(	_	8	punct	_	_
c-fos	NN	B-NP	B-DNA	B-Protein	Yes	No	B-Protein	Other	###	8	c-fos	c-fos	NN	NN	_	6	dep	_	_
and	CC	O	O	Other	No	No	Other	Other	###	9	and	and	CC	CC	_	8	cc	_	_
c-jun	NN	B-NP	B-DNA	B-Protein	Yes	No	B-Protein	Other	###	10	c-jun	c-jun	NN	NN	_	8	conj	_	_
)	)	O	O	Other	No	No	Other	Other	###	11	)	)	)	)	_	8	punct	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	12	by	by	IN	IN	_	13	case	_	_
agents	NNS	B-NP	O	Other	No	No	Other	Other	###	13	agents	agents	NNS	NNS	_	1	nmod	_	_
that	WDT	B-NP	O	Other	No	No	Other	Other	###	14	that	that	WDT	WDT	_	15	nsubj	_	_
enhance	VBP	B-VP	O	Other	No	No	Other	Other	###	15	enhance	enhance	VBP	VBP	_	13	acl:relcl	_	_
mononuclear	JJ	B-NP	B-cell_type	Other	No	No	Other	Other	###	16	mononuclear	mononuclear	JJ	JJ	_	18	amod	_	_
cell	NN	I-NP	I-cell_type	Other	No	No	Other	Other	###	17	cell	cell	NN	NN	_	18	compound	_	_
activity	NN	I-NP	O	Other	No	No	Other	Other	###	18	activity	activity	NN	NN	_	15	dobj	_	_
has	VBZ	B-VP	O	Other	No	No	Other	Other	###	19	has	has	VBZ	VBZ	_	21	aux	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	20	been	been	VBN	VBN	_	21	auxpass	_	_
implicated	VBN	I-VP	O	Other	No	No	Other	B-Regulation	###	21	implicated	implicated	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	22	in	in	IN	IN	_	24	case	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	23	TNF-alpha	TNF-alpha	NN	NN	_	24	compound	_	_
expression	NN	I-NP	O	Other	No	Yes	Other	B-Gene_expression	###	24	expression	expression	NN	NN	_	21	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	25	.	.	.	.	_	21	punct	_	_

Moreover	RB	B-ADVP	O	Other	No	No	Other	Other	###	1	Moreover	Moreover	RB	RB	_	6	advmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	2	,	,	,	,	_	6	punct	_	_
AP-1	NN	B-NP	B-protein	Other	No	No	Other	Other	###	3	AP-1	AP-1	NN	NN	_	6	nsubj	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	4	and	and	CC	CC	_	3	cc	_	_
CREB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	5	CREB	CREB	NN	NN	_	3	conj	_	_
recognize	VBP	B-VP	O	Other	No	No	Other	B-Binding	###	6	recognize	recognize	VBP	VBP	_	0	root	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	7	a	a	DT	DT	_	11	det	_	_
similar	JJ	I-NP	O	Other	No	No	Other	Other	###	8	similar	similar	JJ	JJ	_	11	amod	_	_
DNA	NN	I-NP	B-DNA	Other	No	No	Other	Other	###	9	DNA	DNA	NN	NN	_	11	compound	_	_
binding	NN	I-NP	I-DNA	Other	No	No	Other	Other	###	10	binding	binding	NN	NN	_	11	compound	_	_
sequence	NN	I-NP	I-DNA	Other	No	No	Other	Other	###	11	sequence	sequence	NN	NN	_	6	dobj	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	12	in	in	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	13	the	the	DT	DT	_	15	det	_	_
promoter	NN	I-NP	B-DNA	Other	No	No	Other	Other	###	14	promoter	promoter	NN	NN	_	15	compound	_	_
region	NN	I-NP	I-DNA	Other	No	No	Other	Other	###	15	region	region	NN	NN	_	11	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	16	of	of	IN	IN	_	19	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	17	the	the	DT	DT	_	19	det	_	_
TNF-alpha	NN	I-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	18	TNF-alpha	TNF-alpha	NN	NN	_	19	compound	_	_
gene35	NN	I-NP	O	Other	No	No	Other	Other	###	19	gene35	gene35	NN	NN	_	15	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	20	.	.	.	.	_	6	punct	_	_

Given	VBN	B-PP	O	Other	No	No	Other	Other	###	1	Given	Given	VBN	VBN	_	3	case	_	_
these	DT	B-NP	O	Other	No	No	Other	Other	###	2	these	these	DT	DT	_	3	det	_	_
relationships	NNS	I-NP	O	Other	No	No	Other	Other	###	3	relationships	relationships	NNS	NNS	_	7	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	4	,	,	,	,	_	7	punct	_	_
it	PRP	B-NP	O	Other	No	No	Other	Other	###	5	it	it	PRP	PRP	_	7	nsubj	_	_
is	VBZ	B-VP	O	Other	No	No	Other	Other	###	6	is	is	VBZ	VBZ	_	7	cop	_	_
conceivable	JJ	B-ADJP	O	Other	No	No	Other	Other	###	7	conceivable	conceivable	JJ	JJ	_	0	root	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	8	that	that	IN	IN	_	11	mark	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	9	PTX	PTX	NN	NN	_	11	nsubj	_	_
may	MD	B-VP	O	Other	No	No	Other	Other	###	10	may	may	MD	MD	_	11	aux	_	_
exert	VB	I-VP	O	Other	No	No	Other	Other	###	11	exert	exert	VB	VB	_	7	ccomp	_	_
some	DT	B-NP	O	Other	No	No	Other	Other	###	12	some	some	DT	DT	_	11	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	13	of	of	IN	IN	_	16	case	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	14	its	its	PRP$	PRP$	_	16	nmod:poss	_	_
anti-inflammatory	JJ	I-NP	O	Other	No	No	Other	Other	###	15	anti-inflammatory	anti-inflammatory	JJ	JJ	_	16	amod	_	_
actions	NNS	I-NP	O	Other	No	No	Other	Other	###	16	actions	actions	NNS	NNS	_	12	nmod	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	17	by	by	IN	IN	_	18	mark	_	_
affecting	VBG	B-VP	O	Other	No	No	Other	Other	###	18	affecting	affecting	VBG	VBG	_	11	advcl	_	_
AP-1	NN	B-NP	B-protein	Other	No	No	Other	Other	###	19	AP-1	AP-1	NN	NN	_	20	compound	_	_
activation	NN	I-NP	O	Other	No	No	Other	Other	###	20	activation	activation	NN	NN	_	18	dobj	_	_
and	CC	O	O	Other	No	No	Other	Other	###	21	and	and	CC	CC	_	18	cc	_	_
favoring	VBG	B-VP	O	Other	No	No	Other	Other	###	22	favoring	favoring	VBG	VBG	_	18	conj	_	_
CREB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	23	CREB	CREB	NN	NN	_	24	compound	_	_
binding	NN	I-NP	O	Other	No	No	Other	Other	###	24	binding	binding	NN	NN	_	22	dobj	_	_
,	,	O	O	Other	No	No	Other	Other	###	25	,	,	,	,	_	11	punct	_	_
thus	RB	B-ADVP	O	Other	No	No	Other	Other	###	26	thus	thus	RB	RB	_	27	advmod	_	_
inhibiting	VBG	B-VP	O	Other	No	No	Other	B-Negative_regulation	###	27	inhibiting	inhibiting	VBG	VBG	_	11	advcl	_	_
TNF-alpha	NN	B-NP	B-DNA	B-Protein	Yes	No	B-Protein	Other	###	28	TNF-alpha	TNF-alpha	NN	NN	_	30	compound	_	_
gene	NN	I-NP	I-DNA	Other	No	No	Other	Other	###	29	gene	gene	NN	NN	_	30	compound	_	_
transcription	NN	I-NP	O	Other	No	No	Other	B-Transcription	###	30	transcription	transcription	NN	NN	_	27	dobj	_	_
.	.	O	O	Other	No	No	Other	Other	###	31	.	.	.	.	_	7	punct	_	_

Additional	JJ	B-NP	O	Other	No	No	Other	Other	###	1	Additional	Additional	JJ	JJ	_	2	amod	_	_
studies	NNS	I-NP	O	Other	No	No	Other	Other	###	2	studies	studies	NNS	NNS	_	4	nsubj	_	_
are	VBP	B-VP	O	Other	No	No	Other	Other	###	3	are	are	VBP	VBP	_	4	cop	_	_
necessary	JJ	B-ADJP	O	Other	No	No	Other	Other	###	4	necessary	necessary	JJ	JJ	_	0	root	_	_
to	TO	B-VP	O	Other	No	No	Other	Other	###	5	to	to	TO	TO	_	6	mark	_	_
elucidate	VB	I-VP	O	Other	No	No	Other	Other	###	6	elucidate	elucidate	VB	VB	_	4	xcomp	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	7	the	the	DT	DT	_	9	det	_	_
complex	JJ	I-NP	O	Other	No	No	Other	Other	###	8	complex	complex	JJ	JJ	_	9	amod	_	_
interactions	NNS	I-NP	O	Other	No	No	Other	Other	###	9	interactions	interactions	NNS	NNS	_	6	dobj	_	_
between	IN	B-PP	O	Other	No	No	Other	Other	###	10	between	between	IN	IN	_	11	case	_	_
CREB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	11	CREB	CREB	NN	NN	_	9	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	12	,	,	,	,	_	11	punct	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	13	NF-kappaB	NF-kappaB	NN	NN	_	11	conj	_	_
,	,	O	O	Other	No	No	Other	Other	###	14	,	,	,	,	_	11	punct	_	_
and	CC	O	O	Other	No	No	Other	Other	###	15	and	and	CC	CC	_	11	cc	_	_
AP-1	NN	B-NP	B-protein	Other	No	No	Other	Other	###	16	AP-1	AP-1	NN	NN	_	11	conj	_	_
following	VBG	B-PP	O	Other	No	Yes	Other	Other	###	17	following	following	VBG	VBG	_	19	case	_	_
LPS	NN	B-NP	O	Other	No	No	Other	Other	###	18	LPS	LPS	NN	NN	_	19	compound	_	_
exposure	NN	I-NP	O	Other	No	No	Other	Other	###	19	exposure	exposure	NN	NN	_	9	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	20	and	and	CC	CC	_	19	cc	_	_
PDE	NN	B-NP	O	Other	No	No	Other	Other	###	21	PDE	PDE	NN	NN	_	22	compound	_	_
inhibition	NN	I-NP	O	Other	No	No	Other	Other	###	22	inhibition	inhibition	NN	NN	_	19	conj	_	_
.	.	O	O	Other	No	No	Other	Other	###	23	.	.	.	.	_	4	punct	_	_

Furthermore	RB	B-ADVP	O	Other	No	No	Other	Other	###	1	Furthermore	Furthermore	RB	RB	_	17	advmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	2	,	,	,	,	_	17	punct	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	3	the	the	DT	DT	_	4	det	_	_
effect	NN	I-NP	O	Other	No	No	Other	Other	###	4	effect	effect	NN	NN	_	17	nsubjpass	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	5	of	of	IN	IN	_	6	case	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	6	PTX	PTX	NN	NN	_	4	nmod	_	_
on	IN	B-PP	O	Other	No	No	Other	Other	###	7	on	on	IN	IN	_	10	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	8	the	the	DT	DT	_	10	det	_	_
cGMP	NN	I-NP	O	Other	No	No	Other	Other	###	9	cGMP	cGMP	NN	NN	_	10	compound	_	_
pathway	NN	I-NP	O	Other	No	No	Other	Other	###	10	pathway	pathway	NN	NN	_	4	nmod	_	_
after	IN	B-PP	O	Other	No	No	Other	Other	###	11	after	after	IN	IN	_	13	case	_	_
LPS	NN	B-NP	O	Other	No	No	Other	Other	###	12	LPS	LPS	NN	NN	_	13	compound	_	_
stimulation	NN	I-NP	O	Other	No	No	Other	Other	###	13	stimulation	stimulation	NN	NN	_	4	nmod	_	_
has	VBZ	B-VP	O	Other	No	No	Other	Other	###	14	has	has	VBZ	VBZ	_	17	aux	_	_
not	RB	I-VP	O	Other	No	No	Other	Other	###	15	not	not	RB	RB	_	17	neg	_	_
been	VBN	I-VP	O	Other	No	No	Other	Other	###	16	been	been	VBN	VBN	_	17	auxpass	_	_
explored	VBN	I-VP	O	Other	No	No	Other	Other	###	17	explored	explored	VBN	VBN	_	0	root	_	_
,	,	O	O	Other	No	No	Other	Other	###	18	,	,	,	,	_	17	punct	_	_
although	IN	B-SBAR	O	Other	No	No	Other	Other	###	19	although	although	IN	IN	_	21	mark	_	_
we	PRP	B-NP	O	Other	No	No	Other	Other	###	20	we	we	PRP	PRP	_	21	nsubj	_	_
plan	VBP	B-VP	O	Other	No	No	Other	Other	###	21	plan	plan	VBP	VBP	_	17	advcl	_	_
to	TO	I-VP	O	Other	No	No	Other	Other	###	22	to	to	TO	TO	_	23	mark	_	_
do	VB	I-VP	O	Other	No	No	Other	Other	###	23	do	do	VB	VB	_	21	xcomp	_	_
so	RB	B-ADVP	O	Other	No	No	Other	Other	###	24	so	so	RB	RB	_	23	advmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	25	in	in	IN	IN	_	27	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	26	the	the	DT	DT	_	27	det	_	_
future	NN	I-NP	O	Other	No	No	Other	Other	###	27	future	future	NN	NN	_	23	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	28	.	.	.	.	_	17	punct	_	_

In	IN	B-PP	O	Other	No	No	Other	Other	###	1	In	In	IN	IN	_	2	case	_	_
summary	NN	B-NP	O	Other	No	No	Other	Other	###	2	summary	summary	NN	NN	_	6	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	3	,	,	,	,	_	6	punct	_	_
we	PRP	B-NP	O	Other	No	No	Other	Other	###	4	we	we	PRP	PRP	_	6	nsubj	_	_
have	VBP	B-VP	O	Other	No	No	Other	Other	###	5	have	have	VBP	VBP	_	6	aux	_	_
demonstrated	VBN	I-VP	O	Other	No	No	Other	Other	###	6	demonstrated	demonstrated	VBN	VBN	_	0	root	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	7	that	that	IN	IN	_	14	mark	_	_
PDE	NN	B-NP	O	Other	No	No	Other	Other	###	8	PDE	PDE	NN	NN	_	9	compound	_	_
inhibition	NN	I-NP	O	Other	No	No	Other	Other	###	9	inhibition	inhibition	NN	NN	_	14	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	10	of	of	IN	IN	_	13	case	_	_
human	JJ	B-NP	B-cell_type	Other	No	No	Other	Other	###	11	human	human	JJ	JJ	_	13	amod	_	_
mononuclear	JJ	I-NP	I-cell_type	Other	No	No	Other	Other	###	12	mononuclear	mononuclear	JJ	JJ	_	13	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	No	No	Other	Other	###	13	cells	cells	NNS	NNS	_	9	nmod	_	_
downregulates	VBZ	B-VP	O	Other	No	Yes	Other	B-Negative_regulation	###	14	downregulates	downregulates	VBZ	VBZ	_	6	ccomp	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	15	TNF-alpha	TNF-alpha	NN	NN	_	16	compound	_	_
production	NN	I-NP	O	Other	No	Yes	Other	B-Gene_expression	###	16	production	production	NN	NN	_	14	dobj	_	_
,	,	O	O	Other	No	No	Other	Other	###	17	,	,	,	,	_	14	punct	_	_
at	IN	B-ADVP	O	Other	No	No	Other	Other	###	18	at	at	IN	IN	_	21	advmod	_	_
least	JJS	I-ADVP	O	Other	No	No	Other	Other	###	19	least	least	JJS	JJS	_	18	mwe	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	20	in	in	IN	IN	_	21	case	_	_
part	NN	B-NP	O	Other	No	No	Other	Other	###	21	part	part	NN	NN	_	14	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	22	,	,	,	,	_	14	punct	_	_
through	IN	B-PP	O	Other	No	No	Other	Other	###	23	through	through	IN	IN	_	28	case	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	24	a	a	DT	DT	_	28	det	_	_
PKA	JJ	I-NP	O	Other	No	No	Other	Other	###	25	PKA	PKA	JJ	JJ	_	28	amod	_	_
-	-	O	O	Other	No	No	Other	Other	###	26	-	-	-	-	_	28	punct	_	_
independent	JJ	I-NP	O	Other	No	Yes	Other	B-Regulation	###	27	independent	independent	JJ	JJ	_	25	dep	_	_
mechanism	NN	I-NP	O	Other	No	No	Other	Other	###	28	mechanism	mechanism	NN	NN	_	14	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	29	.	.	.	.	_	6	punct	_	_

In	IN	B-PP	O	Other	No	No	Other	Other	###	1	In	In	IN	IN	_	2	case	_	_
addition	NN	B-NP	O	Other	No	No	Other	Other	###	2	addition	addition	NN	NN	_	5	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	3	,	,	,	,	_	5	punct	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	4	PTX	PTX	NN	NN	_	5	nsubj	_	_
attenuates	VBZ	B-VP	O	Other	No	No	Other	Other	###	5	attenuates	attenuates	VBZ	VBZ	_	0	root	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	6	the	the	DT	DT	_	7	det	_	_
activity	NN	I-NP	O	Other	No	No	Other	Other	###	7	activity	activity	NN	NN	_	5	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	8	of	of	IN	IN	_	9	case	_	_
NF-B	NN	B-NP	B-protein	Other	No	No	Other	Other	###	9	NF-B	NF-B	NN	NN	_	7	nmod	_	_
while	IN	B-SBAR	O	Other	No	No	Other	Other	###	10	while	while	IN	IN	_	11	mark	_	_
upregulating	VBG	B-VP	O	Other	No	No	Other	Other	###	11	upregulating	upregulating	VBG	VBG	_	5	advcl	_	_
CREB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	12	CREB	CREB	NN	NN	_	13	compound	_	_
activation	NN	I-NP	O	Other	No	No	Other	Other	###	13	activation	activation	NN	NN	_	11	dobj	_	_
after	IN	B-PP	O	Other	No	No	Other	Other	###	14	after	after	IN	IN	_	16	case	_	_
LPS	NN	B-NP	O	Other	No	No	Other	Other	###	15	LPS	LPS	NN	NN	_	16	compound	_	_
stimulation	NN	I-NP	O	Other	No	No	Other	Other	###	16	stimulation	stimulation	NN	NN	_	11	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	17	,	,	,	,	_	11	punct	_	_
which	WDT	B-NP	O	Other	No	No	Other	Other	###	18	which	which	WDT	WDT	_	20	nsubj	_	_
may	MD	B-VP	O	Other	No	No	Other	Other	###	19	may	may	MD	MD	_	20	aux	_	_
result	VB	I-VP	O	Other	No	No	Other	Other	###	20	result	result	VB	VB	_	5	dep	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	21	in	in	IN	IN	_	22	case	_	_
modulation	NN	B-NP	O	Other	No	No	Other	Other	###	22	modulation	modulation	NN	NN	_	20	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	23	of	of	IN	IN	_	26	case	_	_
pro-inflammatory	JJ	B-NP	B-protein	Other	No	No	Other	Other	###	24	pro-inflammatory	pro-inflammatory	JJ	JJ	_	26	amod	_	_
mediator	NN	I-NP	I-protein	Other	No	No	Other	Other	###	25	mediator	mediator	NN	NN	_	26	compound	_	_
synthesis	NN	I-NP	O	Other	No	Yes	Other	Other	###	26	synthesis	synthesis	NN	NN	_	22	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	27	.	.	.	.	_	5	punct	_	_

Therefore	RB	B-ADVP	O	Other	No	No	Other	Other	###	1	Therefore	Therefore	RB	RB	_	5	advmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	2	,	,	,	,	_	5	punct	_	_
PTX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	3	PTX	PTX	NN	NN	_	5	nsubj	_	_
may	MD	B-VP	O	Other	No	No	Other	Other	###	4	may	may	MD	MD	_	5	aux	_	_
serve	VB	I-VP	O	Other	No	No	Other	Other	###	5	serve	serve	VB	VB	_	0	root	_	_
as	IN	B-PP	O	Other	No	No	Other	Other	###	6	as	as	IN	IN	_	9	case	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	7	a	a	DT	DT	_	9	det	_	_
potential	JJ	I-NP	O	Other	No	No	Other	Other	###	8	potential	potential	JJ	JJ	_	9	amod	_	_
adjunct	NN	I-NP	O	Other	No	No	Other	Other	###	9	adjunct	adjunct	NN	NN	_	5	nmod	_	_
therapeutic	JJ	B-ADJP	O	Other	No	No	Other	Other	###	10	therapeutic	therapeutic	JJ	JJ	_	9	amod	_	_
for	IN	B-PP	O	Other	No	No	Other	Other	###	11	for	for	IN	IN	_	13	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	12	the	the	DT	DT	_	13	det	_	_
treatment	NN	I-NP	O	Other	No	No	Other	Other	###	13	treatment	treatment	NN	NN	_	10	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	14	of	of	IN	IN	_	15	case	_	_
conditions	NNS	B-NP	O	Other	No	No	Other	Other	###	15	conditions	conditions	NNS	NNS	_	13	nmod	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	16	in	in	IN	IN	_	17	case	_	_
which	WDT	B-NP	O	Other	No	No	Other	Other	###	17	which	which	WDT	WDT	_	20	nmod	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	18	TNF-alpha	TNF-alpha	NN	NN	_	19	compound	_	_
production	NN	I-NP	O	Other	No	Yes	Other	B-Gene_expression	###	19	production	production	NN	NN	_	20	nsubj	_	_
plays	VBZ	B-VP	O	Other	No	No	Other	Other	###	20	plays	plays	VBZ	VBZ	_	15	acl:relcl	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	21	a	a	DT	DT	_	23	det	_	_
significant	JJ	I-NP	O	Other	No	No	Other	Other	###	22	significant	significant	JJ	JJ	_	23	amod	_	_
role	NN	I-NP	O	Other	No	No	Other	Other	###	23	role	role	NN	NN	_	20	dobj	_	_
.	.	O	O	Other	No	No	Other	Other	###	24	.	.	.	.	_	5	punct	_	_

